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Role Of Maternal Sin3a In Reprogramming Gene Expression During Mouse
Preimplantation Development
Abstract
In mouse, the maternal-to-zygotic transition entails a dramatic reprogramming of gene expression during
the course of zygotic genome activation, which is essential for continued development beyond the 2-cell
stage. Superimposed on zygotic genome activation and reprogramming of gene expression is formation
of a chromatin-mediated transcriptionally repressive state that promotes repression of genes at the 2-cell
stage. Experimentally inducing global histone hyperacetylation relieves this repression and histone
deacetylase 1 (HDAC1) is the major HDAC involved in the development of this transcriptionally repressive
state. Because SIN3A is essential for mouse development and is part of a HDAC1/2-containing complex, I
investigated the role of maternal SIN3A in the development of the global transcriptionally repressive state
that develops during the course of genome activation and reprogramming. In addition, previous
microarray data generated from our lab of oligo (dT) primed mouse oocyte and 1-cell embryo cDNA
revealed an elevation in the relative abundance of the Sin3a transcript between the oocyte and 1-cell
stages; the elevation in relative transcript abundance suggests that the Sin3a transcript undergoes
translational recruitment during oocyte maturation because the elevation occurs during a period of
transcriptional quiescence. Here I show that the Sin3a transcript is recruited for translation during oocyte
maturation and following fertilization. I demonstrated that maternal SIN3A is essential for
preimplantation development and the reprogramming of genes expression, because inhibiting the
maturation-associated increase in SIN3A leads to an arrest in mouse embryonic development and
unfaithful reprogramming of gene expression in 2-cell mouse embryos. The mid 1-cell embryo contains
the maximum level of maternal SIN3A protein and the protein then rapidly decreases to essentially an
undetectable level by the mid 2-cell stage; the rapid loss of maternal SIN3A is likely mediated by the
proteasome because a proteasome inhibitor substantially inhibits the loss of maternal SIN3A. Due to the
restricted presence of the maturation-associated increase in SIN3A, the function of maternal SIN3A is
likely constrained to the 1-cell stage of mouse development. However, the increase in maternal SIN3A
does not play a role in the minor ZGA, as depleting maternal SIN3A had no effect on global transcription in
1-cell embryos, but surprisingly results in histone hypoacetylation in 1-cell mouse embryos. Maintaining
the presence of maternal SIN3A beyond the 1-cell stage had no effect on pre- and postimplantation
development. Collectively, these findings indicate that the maturation-associated increase in SIN3A
regulates the reprogramming of gene expression and the oocyte may utilize the translational recruitment
of transcripts encoding chromatin-modifying-related factors during oocyte maturation as a posttranscriptional mechanism to faithfully execute the reprogramming of gene expression through the
utilization of a maternally-derived transcription machinery.
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ABSTRACT
ROLE OF MATERNAL SIN3A IN REPROGRAMMING GENE EXPRESSION
DURING MOUSE PREIMPLANTATION DEVELOPMENT
Richard A. Jiménez
Richard M. Schultz
In mouse, the maternal-to-zygotic transition entails a dramatic reprogramming of
gene expression during the course of zygotic genome activation, which is
essential for continued development beyond the 2-cell stage. Superimposed on
zygotic genome activation and reprogramming of gene expression is formation of
a chromatin-mediated transcriptionally repressive state that promotes repression
of genes at the 2-cell stage. Experimentally inducing global histone
hyperacetylation relieves this repression and histone deacetylase 1 (HDAC1) is
the major HDAC involved in the development of this transcriptionally repressive
state. Because SIN3A is essential for mouse development and is part of a
HDAC1/2-containing complex, I investigated the role of maternal SIN3A in the
development of the global transcriptionally repressive state that develops during
the course of genome activation and reprogramming. In addition, previous
microarray data generated from our lab of oligo (dT) primed mouse oocyte and 1cell embryo cDNA revealed an elevation in the relative abundance of the Sin3a
transcript between the oocyte and 1-cell stages; the elevation in relative
transcript abundance suggests that the Sin3a transcript undergoes translational
recruitment during oocyte maturation because the elevation occurs during a
period of transcriptional quiescence. Here I show that the Sin3a transcript is
recruited for translation during oocyte maturation and following fertilization. I
demonstrated that maternal SIN3A is essential for preimplantation development
and the reprogramming of genes expression, because inhibiting the maturationassociated increase in SIN3A leads to an arrest in mouse embryonic
development and unfaithful reprogramming of gene expression in 2-cell mouse
iv

embryos. The mid 1-cell embryo contains the maximum level of maternal SIN3A
protein and the protein then rapidly decreases to essentially an undetectable
level by the mid 2-cell stage; the rapid loss of maternal SIN3A is likely mediated
by the proteasome because a proteasome inhibitor substantially inhibits the loss
of maternal SIN3A. Due to the restricted presence of the maturation-associated
increase in SIN3A, the function of maternal SIN3A is likely constrained to the 1cell stage of mouse development. However, the increase in maternal SIN3A
does not play a role in the minor ZGA, as depleting maternal SIN3A had no effect
on global transcription in 1-cell embryos, but surprisingly results in histone
hypoacetylation in 1-cell mouse embryos. Maintaining the presence of maternal
SIN3A beyond the 1-cell stage had no effect on pre- and postimplantation
development. Collectively, these findings indicate that the maturation-associated
increase in SIN3A regulates the reprogramming of gene expression and the
oocyte may utilize the translational recruitment of transcripts encoding chromatinmodifying-related factors during oocyte maturation as a post-transcriptional
mechanism to faithfully execute the reprogramming of gene expression through
the utilization of a maternally-derived transcription machinery.
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CHAPTER 1: INTRODUCTION
1.1 Overview of mouse oogenesis and preimplantation development
Mammalian oocytes embark on the path to fertilization and embryogenesis
within the functional unit of the ovary, the ovarian follicle. Each follicle is
composed of a single oocyte arrested in prophase I of meiosis enclosed by one
or more layers of specialized somatic cells that communicate with and support
the oocyte during its growth and development via gap junctions. Starting with a
resting or primordial follicle that comprises of an oocyte surrounded by a single
layer of squamous, flattened, pre-granulosa cells, each primordial follicle’s
prolonged resting phase is interrupted by factors that recruit the follicle for
development into a primary follicle. The size of the initial primordial follicle pool
in part dictates reproductive senescence in females.
Since the 1950s, the prevailing view was that mammalian females are
provided with an extensive, but finite, nonrenewable ovarian reserve around the
time of birth for mice or during mid-gestation in humans, which is diminished as
the follicles are recruited to grow (Zuckerman, 1951). However, some
investigators challenge the 50-year dogma and contend that the ovarian reserve
could be replenished by female germline stem cells referred to as oogonial stem
cells. These paradigm-shifting studies claim that a population of cells isolated
from both neonatal and adult mouse ovaries and adult human ovaries have stem
cell characteristics and, specifically for the cells isolated from mouse ovaries, are
capable of differentiating into oocytes that are able to mature, ovulate, and
fertilize to produce viable embryos and pups (Johnson et al., 2004; Pacchiarotti
et al., 2010; Zou et al., 2009; White et al., 2012). The surface protein used to
isolate the oogonial stem cells from the ovarian tissue, and the condition of the
human ovarian tissues used to isolate the human stem cell-like cells are
questionable and need to be investigated more thoroughly in order to definitively
determine if the ovarian reserve can be replenished.
The regulatory factors primarily responsible for activation of primordial
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follicles are locally produced (Kezele et al., 2002) and include epithelial growth
factor kit ligand (KITL), leukemia inhibiting factor (LIF), basic fibroblast growth
factor (BFGF), platelet derived growth factor (PDGF), keratinocyte growth factor
(KGF) and connective tissue growth factor (CTGF) (Kezele et al., 2005; Nilsson
et al., 2006; Nilsson and Skinner, 2004; Skinner, 2005; Schindler et al., 2010).
KITL activates the ubiquitous phosphatidylinositol-3-kinase (PI3K) signaling
pathway, which is important for the activation and survival of primordial follicles
because removal of PTEN, a PI3K antagonist, leads to premature activation of
follicles in mouse (Reddy et al., 2008; John et al., 2008). Once the primordial
follicle is activated, the surrounding squamous pre-granulosa cells differentiate
into cuboidal granulosa cells and begin to proliferate, while the oocyte grows
remarkably (increases in size from about 20 µm to 80 µm in diameter) (Eppig and
O’Brien, 1996). The growing primary follicles will subsequently develop into
secondary and antral follicles.
After exposure to a preovulatory surge of luteinizing hormone (LH) from
the pituitary gland, mammalian oocytes overcome meiotic arrest and proceed
through meiotic maturation before ovulating (Russell et al., 2007). An increase in
the activity of maturation-promoting factor (MPF), a cyclin B-CDK1 complex,
drives meiotic progression of mammalian oocytes (Nurse, 1990). Mitogenactivated protein kinase (MAPK) cascade is another important kinase necessary
for resumption of meiosis that interacts intimately with the MPF pathway in many
species except for mice (Verlhac et al., 1993), where a normal pattern of MPF
activity is seen when the MAPK cascade is disrupted in mice lacking c-MOS, a
MAPK pathway activator (Araki et al., 1996).
Meiotic maturation entails nuclear membrane breakdown (germinal vesicle
breakdown, GVBD), meiosis I spindle assembly, extrusion of the first polar body,
and meiosis II spindle assembly. Also, a meiosis-specific deacetylation of
histones occurs during meiotic maturation in mouse, where all of the acetylated
histones examined, with the exception of H4K8ac, are deacetylated to
undetectable levels at the end of meiosis (Kim et al., 2003). Global deacetylation
2

shortly after meiotic resumption may facilitate chromosome condensation that
occurs during oocyte maturation because hyperacetylation of H4K16 likely
contributes to defective chromosome condensation observed in histone
deacetylase 2 (Hdac2) null mouse oocytes (Ma and Schultz, 2013). Meiotic
maturation is complete after arrest at metaphase of meiosis II. Mouse oocytes
acquire meiotic competence in a stepwise manner at the time of follicular antrum
formation, where they first acquire the ability to reinitiate meiosis but are unable
to complete meiosis I and, at a later time, acquire the capacity to complete
meiosis I and progress to metaphase of meiosis II (Szybek, 1972; Sorensen and
Wassarman, 1976; Wickramasinghe et al., 1991). However, meiotically
competent oocytes are unable to support preimplantation embryonic
development until additional metabolic and structural modifications are acquired
during the periovulatory period (Eppig et al., 1994; Eppig, 1996). Competence to
complete preimplantation development is also acquired by growing oocytes in a
stepwise manner where they initially acquire the capacity to undergo fertilization
and development to the 2-cell stage, and later acquire competence to develop
from the 2-cell stage to the blastocyst stage (Eppig and Schroeder, 1989).
After ovulation, the metaphase II arrested mouse egg is fertilized within
the oviduct, which triggers the completion of meiosis and formation of a 1-cell
embryo. The newly formed 1-cell embryo enters the first mitotic cell cycle that
begins with a prolonged Gap 1 (G1) phase during which two spatially separated
maternal and paternal haploid pronuclei form, with the larger paternal pronucleus
forming first between 4 and 8 hours post-fertilization (hpf) and the maternal
pronucleus forming between 5 and 9.5 hpf (Howlett and Bolton, 1985). Each
pronucleus undergoes DNA replication before entering the first mitosis to
produce a 2-cell embryo, which continues to undergo successive reductive
cleavage divisions without a significant increase in cell volume to form the 4-cell
embryo, 8-cell embryo, and later the blastocyst (Lehtonen, 1980).
By the late 2-cell stage, the initiation of de novo transcription from the
newly formed embryonic genome, known as embryonic genome activation (EGA)
3

or zygotic gene activation (ZGA), has occurred. ZGA occurs in two phases: (i)
minor ZGA occurs at the late one-cell stage, which results in a low-level of global
transcriptional activation and generation of non-functional transcripts because
they are inefficiently spliced and polyadenylated (Latham et al., 1991; Park et al.,
2013; Abe et al., 2015), and (ii) major ZGA occurs at the late two-cell stage,
which generates distinct functional transcripts that are not expressed in the germ
cells, thus promoting a dramatic reprogramming of gene expression (Zeng et al.,
2005; Hamatani et al., 2004). Interestingly, when transcription in mice was
analyzed at the 1-cell stage either using a luciferase plasmid-born reporter gene
or BrUTP incorporation to assess endogenous gene transcription, enhanced
luciferase expression or BrUTP incorporation was observed from the male
pronucleus (Ram and Schultz, 1993; Wiekowski et al., 1993; Aoki et al., 1997).
This transcription is about four to five times greater in the male pronucleus than
that of the female pronucleus, which is consistent with a greater concentration of
transcription factors present in the male pronucleus, such as the TATA-box
binding protein (TBP) and SP1 transcription factor (Ram and Schultz, 1993;
Wiekowski et al., 1993; Worrad et al., 1994). The difference in the transcriptional
activity and transcription factor concentration between the male and female
pronucleus may likely reflect the difference in chromatin organization between
the two pronculei. As discussed below, the male pronucleus exchanges the
sperm-derived protamines that densely package the sperm DNA for maternallyderived histones during pronuclear formation (Nonchev and Tsanev, 1990),
thereby providing a more open chromatin structure for transcription factors to
associate preferentially with and likely enhancing the transcriptional activity of the
male pronucleus.
During the 8-cell stage, the first grossly morphological differentiation of the
embryo occurs: compaction. Compaction is where the individual blastomeres
become nearly indistinguishable due to the formation of desmosomes and gap
junctions between the blastomeres (Johnson and Marco, 1986; Fleming et al.,
2001). The cell adhesion surface molecule E-cadherin mediates the calcium4

dependent compaction process because E-cadherin null embryos fail to maintain
compaction, in addition to failing to form an intact trophectodermal epithelium or
a blastocoele cavity (Larue et al., 1994). Following compaction, further cleavage
divisions and blastocoele cavity formation, a blastocyst is formed. The blastocyst
stage represents the first cellular differentiation event during development where
two distinct cellular populations are formed: an outer layer of trophectoderm (TE)
cells that give rise to extraembryonic tissues and allow for embryo implantation,
and an inner layer of inner cell mass (ICM) cells, which gives rise to the embryo
proper. One day after the formation of the blastocyst, the mouse embryo
implants into the uterine wall, which marks the completion of preimplantation
development.
1.2 Global transcriptional repression and large-scale changes to chromatin
structure in mouse oocytes
Towards the end of the oocyte growth phase, a dramatic change in the
transcriptional activity and chromatin organization occurs (Bouniol-Bay et al.,
1999). Global transcription within the full-grown oocyte rapidly ceases and the
oocyte becomes transcriptionally inactive and remains largely inactive until the 2cell stage is reached in mouse (Moore and Lintern-Moore, 1978). The chromatin
in mouse oocytes progressively transforms from a decondensed configuration
(referred to as non-surrounded nucleolus, NSN) to a condensed configuration
(surrounded nucleolus, SN) during the final stages of oocyte growth (Debey et
al., 1993). This alteration in chromatin organization is temporally correlated with
but not required for global transcriptional repression in mammalian oocytes
because global transcription is repressed in nucleoplasmin 2 (Npm2) null oocytes
despite failing to remodel their chromatin into the SN configuration (Bouniol-Bay
et al., 1999; Burns et al., 2003; De La Fuente et al., 2004). It has been
suggested that the condensed chromatin configuration and silencing of global
transcription is not only needed for effective resumption and completion of
meiosis by mouse oocytes but is also needed for the subsequent activation of the
5

egg (Liu et al., 2002).
The mechanism responsible for this large-scale chromatin structure
alteration and global silencing of transcription in mouse oocytes remains to be
determined. However, histone deacetylases (HDACs) may participate in the
maintenance of the SN chromatin configuration in mouse oocytes (De La Fuente
et al., 2004); exposing transcriptionally quiescent, full-grown mouse oocytes
exhibiting the SN configuration to trichostatin A (TSA), an inhibitor of HDACs
(Yoshida et al., 1995), induced large-scale chromatin structure decondensation
without restoring the transcriptional activity of the oocyte. However, TSA
exposure had no effect on the immunostaining patterns of histone H3 and H4
acetylation. The observed failure to restore transcriptional activity in oocytes that
underwent chromatin condensation after TSA treatment is consistent with the
observation that Npm2 null mouse oocytes are still able to undergo
transcriptional silencing despite failing to undergo chromatin condensation (Burns
et al., 2003; De La Fuente et al., 2004).
Changes in the nuclear availability or expression levels of several
transcription factors like the TBP and SP1 transcription factor may be responsible
for global transcriptional repression in mouse oocytes. Interestingly, the nuclear
concentration of both TBP and SP1 decreases during oocyte growth and then
increases following fertilization, which is near the time global transcription
reinitiates (Worrad et al., 1994). Another locus of regulation may be at the level
of the RNA polymerase II holoenzyme itself because a decline in the RNA
polymerase II (Pol II) activity was seen as the oocyte reached maximum size
(Moore and Lintern-Moore, 1978). In somatic cells, transcription involves a cycle
of phosphorylation and dephosphorylation of the carboxy-terminal domain (CTD)
of Pol II, specifically the largest subunit RPB1, and therefore may be invovled in
global repression of transcription in mouse oocytes (Dahmus, 1996). Several
studies have examined the phosphorylation status of RPB1 and found that the
CTD of RPB1 undergoes phosphorylation through the action of MAPK during
meiotic maturation (Wei et al., 2015; Abe et al., 2010). When the localization of
6

RPB1 was investigated after permeabilizing the nuclear membrane before
fixation, RPB1 was absent from the nuclei of full-grown mouse oocytes, although
it remained in the nuclei of growing oocytes. This suggests that Pol II is
dissociated from DNA in full-grown oocytes and may be the cause of global
repression of transcription in mouse oocytes. Phosphorylation may destabilize
the RNA polymerase II holoenzyme and lead to the dissociation of RNA
polymerase II from the DNA. However, how CTD phosphorylation contributes to
the abolishment of global transcription in mouse oocytes is not known and needs
to be investigated further.
1.3 Zygotic gene activation
ZGA serves two functions for embryonic development. The first function is
to replace maternal transcripts with embryonic transcripts that are common to the
oocyte and embryo like tubulin (Schultz, 1993; Davis et al., 1996). Expression of
these transcripts is essential for further development but does not contribute to
the reprogramming of gene expression, although they are part of the gene
expression program. The second function of ZGA is to promote a dramatic
reprogramming of gene expression by transcribing a new set of mRNAs that are
not expressed in the sperm or oocyte. Support for the second function of ZGA
was initially shown by analysis of high-resolution, two-dimensional gels, which
revealed that a dramatic reprogramming in the pattern of protein expression
occurred during the late 1-cell and mid 2-cell stages (Latham et al., 1991).
However, only the change in the pattern of protein synthesis that occurred at the
2-cell stage was dependent on de novo RNA transcription because the synthesis
of several polypeptides at the 2-cell stage was inhibited by an RNA polymerase II
inhibitor (i.e., α-amanitin), whereas the pattern of protein synthesis at the 1-cell
stage was unaffected by α-amanitin (Flach et al., 1982; Bolton et al., 1984).
Although an observable change in the pattern of protein synthesis by α-amanitin
was not seen at the 1-cell stage, it is plausible that proteins affected during 1-cell
stage are below the detection limit of the studies’ experimental design.
7

Interestingly, cleavage of 2-cell embryos to the 4-cell stage was inhibited by αamanitin, whereas cleavage of the 1-cell to 2-cell stage was unaffected (Flach et
al., 1982; Bolton et al., 1984). This result suggests that the expression of these
new sets of genes at the 2-cell stage is essential for continued development
beyond the 2-cell stage because perturbing their expression with an RNA
polymerase II inhibitor (i.e., α-amanitin) results in an early embryonic arrest. The
reprogramming process is likely essential for transforming a highly differentiated
oocyte and sperm into a totipotent blastomere, and if this crucial step is not
successfully performed, it is plausible that a developmental checkpoint prevents
further development of the embryo.
1.4 Transcriptionally repressive state
Superimposed on zygotic genome activation (ZGA) is the development of
a transcriptionally repressive state. Several lines of evidence support the
developmental acquisition of a repressive state in the 2-cell embryo. Studies
using luciferase plasmid-born reporter genes driven by the thymidine kinase (tk)promoter demonstrated that by the 2-cell stage efficient luciferase expression
requires an enhancer, e.g., the embryo-responsive polyomavirus F101 enhancer
(Wiekowski et al., 1991; Majumder et al., 1993). Enhancers are regulatory DNA
elements that confer transcriptional activation by recruiting RNA polymerase,
histone modifying enzymes or chromatin remodelers to promoters in a distanceand orientation- independent manner (Johnson and Bresnick, 2002). The
requirement for an enhancer following genome activation during the 2-cell stage
suggests formation of a transcriptionally repressive state that is relieved by an
enhancer. Moreover, the strength of the transcriptionally repressive state
increases with development because the level of enhancer-mediated stimulation
of luciferase expression increased as 2-cell embryos developed into 4-cell
embryos (Henery et al., 1995). Establishment of this repressive state involves
DNA replication; inhibiting the second round of DNA replication with aphidicolin
relieves the requirement for an enhancer for efficient transcription (Wiekowski et
8

al., 1991; Henery et al., 1995).
Inducing histone acetylation by treating mouse embryos with butyrate,
which is another inhibitor of histone deacetylases, also relieves the repression in
2-cell embryos. Histone hyperacetylation lead to an 18-fold stimulation of a
promoter lacking an enhancer and reduced the enhancer stimulation of a
promoter to only 2-fold in 2-cell embryos (Wiekowski et al., 1991).
Experimentally induced histone hyperacetylation also relieves the repression
observed for the expression of endogenous genes that transiently increases
between the 1-cell and mid 2-cell stage, and then decreases by the late 2-cell/4cell stage. A normal decrease in expression of endogenous genes like Eif1a is
seen with formation of the transcriptionally repressive state, which is prevented
when histone hyperacetylation is induced (Davis et al., 1996). The repression of
endogenous genes is believed to be global because inducing histone
hyperacetylation results in a 2-fold increase in the extent of global BrUTP
incorporation during the 2-cell stage (Aoki et al., 1997). The increase in the total
amount of BrUTP in the presence of a histone deacetylase inhibitor indicates an
increase in global transcription due to a global relief of transcriptional repression.
Therefore, formation of an enhancer and histone hyperacetylation responsive
transcriptionally repressive state by the 2-cell stage of development is likely
mediated by changes in histone acetylation and thus global changes in chromatin
structure.
Histone hyperacetylation also inhibited development of mouse embryos
beyond the 2-cell stage. Experimentally inducing histone hyperacetylation in 2cell embryos using TSA prevented cleavage to the 4-cell stage, whereas
treatment of 1-cell embryos with TSA did not inhibit cleavage to the 2-cell stage
(Ma et al., 2001). Formation of the chromatin-mediated transcriptionally
repressive state may be essential for further development because relief of this
repressive state by inducing histone hyperacetylation prevents cleavage of 2-cell
embryos. Histone deacetylase 1 (HDAC1) is the major HDAC involved in the
development of this transcriptionally repressive state. Knockdown of HDAC1, but
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not HDAC2 in preimplantation embryos leads to hyperacetylation of histone H4
and prevented the normal decrease in expression of some endogenous genes
including Eif1a (Ma and Schultz, 2008). These results are consistent with the
results observed following treatment of embryos with TSA. However, induction of
histone hyperacetylation following depletion of HDAC1 in 2-cell embryos did not
stimulate global transcription as observed following treatment with TSA. A likely
explanation for this difference is that TSA treatment induces a more profound
increase in histone acetylation than that observed following depletion of HDAC1.
The role of the transcriptionally repressive state during the 2-cell stage of
development needs to be further investigated. It is likely that the development of
the repressive stage is needed to sculpt and refine the global ZGA process that
is occurring at around the same time that the repressive state is formed. A
foreseen consequence of a global process such as ZGA may be the
inappropriate expression of many genes that are not conducive to the continued
development of the embryo. Formation of a transcriptionally repressive state
may decrease or terminate expression of the inappropriately activated genes, but
allow the continued expression of genes that are regulated by strong promoters
or enhancers that are able to relieve the newly formed transcriptionally
repressive state.
1.5 Epigenetic reprograming in the zygote
Chromatin organization and epigenetic modifications of the male and
female genomes are distinct at fertilization. The male and female genomes are
also in different stages of the cell cycle at insemination; the male genome has
completed meiosis, whereas the female genome is arrested at metaphase II and
needs to complete the second meiotic division. Two different types of epigenetic
modifications occur during zygotic development. One type occurs at the
chromatin level, whereas the other occurs at the DNA methylation level. Upon
fertilization, but before the first round of DNA replication, the unique, highly
condensed protamine-rich chromatin of the sperm changes dramatically; the
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protamines are rapidly exchanged with maternally-derived histones, whereas the
maternal genome essentially retains a chromatin structure present at fertilization
(Nonchev and Tsanev, 1990). The exchange and assembly of the new
nucleosomes on the paternal genome requires histone chaperones. Specifically,
histone variant H3.3-containing nucleosomes are assembled onto the sperm
DNA and this process requires the H3.3-specific histone chaperone protein
HIRA. Loss of maternal HIRA in mouse zygotes leads to a paternal genome
devoid of acetylated-H4, H2A and H3.3 (Lin et al., 2014; Loppin et al., 2005).
Histone replacement on the paternal genome affords the newly formed
embryo a unique window of opportunity to dramatically remodel its chromatin.
Once the histones are assembled and incorporated into the nucleosomes,
changes in the acetylation and methylation pattern can occur. Histones of both
the maternal and paternal genome become acetylated soon after fertilization,
with the paternal chromatin appearing more acetylated when compared to the
maternal chromatin (Adenot et al., 1997; Santos et al., 2002). Soon after histone
acquisition of the paternal genome, the methylation status of the histones in the
newly assembled nucleosomes changes also. The paternal chromatin initially
lacks H3K4me1 and H3K4me3 (active marks), H3K9me1, H3K9me2 and
H3K9me3, H3K27me1, H3K27me2 and H3K27me3, and H4K20me3 (repressive
marks), whereas the maternal genome maintains all of these histone
modifications. However, the paternal chromatin gains new histone posttranslational modifications such as H3K9me1 and H3K27me1 immediately after
the protamine-histone exchange (Santos et al., 2005), and gains H3K4me1 and
H3K4me3, H3K9me2, H3K27me2 and H3K27me3 modifications later during
pronuclear development (Erhardt et al., 2003; Lepikhov and Walter, 2004; Liu et
al., 2004). The de novo appearance of histone methylation modifications within
the paternal pronucleus at histone residues that can sustain alternative histone
modifications indicates that a rapid deacetylation and subsequent
monomethylation process by histone deacetylases and monomethyltransferases
has occurred at these sites. SET 7/9 methyltransferases are needed for K3K4
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monomethylation, G9a and ESET methyltransferases are needed for K3K9me1,
and the monomethyltransferases, EZH1/EED and EZH2/EED are responsible for
H3K27me1 (Wang et al., 2001; Tachibana et al., 2002; Shen et al., 2008). The
new histone modifications accumulating in the paternal pronucleus conceivably
shapes the newly formed paternal chromatin to a state equivalent to the mature
maternal chromatin.
At the time of fertilization, the epigenetic modifications at the DNA level
are diverse and change dramatically during zygotic development. The two
genomes contain sex-specific 5-methlycytosine (5mC) patterns, which are
acquired during development of the gametes. The global DNA methylation level
in the paternal haploid genome is high, with 80%-90% of all CpG dinucleotides
being methylated (Mayer et al., 2000; Santos et al., 2002; Peat et al., 2014). The
female haploid genome is less heavily methylated in the oocyte, where about
40% of all CpG dinucleotides are methylated (Howlett and Reik, 1991;
Smallwood et al., 2011; Peat et al., 2014). Interestingly, over a decade ago, two
pivotal studies observed by different methods that fertilization triggers rapid
global and active loss of DNA methylation within the paternal genome, but not its
maternal counterpart (Mayer et al., 2000; Oswald et al., 2000). The initiation of
this active DNA demethylation occurs shortly after histone acquisition of the
paternal genome as evaluated by indirect immunofluorescence (Mayer et al.,
2000; Dean et al., 2001; Santos et al., 2002; Beaujean et al., 2004; Fulka et al.,
2004) and by bisulphite sequencing at specific loci (Oswald et al., 2000; Lane et
al., 2003).
Recently, a vital enzyme responsible for mediating active DNA
demethylation during preimplantation development was discovered to be TET3
(Iqbal et al., 2011; Gu et al., 2011; Wossidlo et al., 2011). TET3 asymmetrically
localizes to the paternal pronucleus and is absent from the female pronucleus
potentially due to inhibition by PGC7/Stella binding to the H3K9me2 enriched
maternal genome (Gu et al., 2011; Nakamura et al., 2012). TET3 is part of the
Ten-eleven translocation (TET) family of dioxygenases that includes TET1 and
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TET2 (Ito et al., 2010, Thiliani et al., 2009). TET3 mediates the oxidation of the
paternal 5mC to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5carboxylcytosine (5caC), which are gradually lost during each successive
reductive cleavage division along with the maternal 5mC (Inoue et al., 2011;
Inoue and Zhang, 2011; Rougier et al., 1998). Deletion of maternal TET3 leads
to a retention of 5mC in the paternal pronucleus and reduced fecundity (Gu et al.,
2011). It is unclear what role the demethylation process has on development of
the embryo, but the erasure of the specialized germ cell epigenetic memory may
be essential to generate a clean, baseline state on which to build upon to create
a new DNA landscape for the viability of the embryo since perturbing one of the
demehtylation mechanisms leads to a reduction of embryo viability.
1.6 SIN3A-co-represssor complex and HDAC1/2-containing complexes
The SIN3A co-repressor complex, composed of SWI-independent-3
homolog A (SIN3A), histone deacetylase 1/2 (HDAC1/2), suppressor of defective
silencing protein 3 (SDS3), retinoblastoma binding protein 4/7 (RBBP4/7),
SIN3A-associated protein 30/130/180 (SAP30/130/180), SIN3A associated
protein 18 (SAP18), retinoblastoma-binding protein 1 (RBP1), inhibitor of growth
family, member 1/2 (ING1/2), breast cancer metastasis suppressor 1 (BRMS1),
family with sequence similarity 60, member A (FAM60A), PHD finger protein 12
(PHF12), and mortality factor 4 like 1 (MORF4L1), interacts with transcription
factors like TP53, SOX2, E2F4 and Krüppel-like factor 11 (KLF11) (Smith et al.,
2012; Kadamb et al., 2013; Bansal et al., 2015). With no enzymatic or
recognizable DNA-binding activity, the highly conserved SIN3A protein acts as a
scaffold upon which a diverse set of proteins dock (Silverstein and Ekwall, 2005).
This scaffolding role of SIN3A makes it an essential component of the multisubunit SIN3A co-repressor complex that has been described in many organisms
from plants to humans (Hill et al., 2008; Hassig et al., 1997). Due to its
scaffolding function, SIN3A allows for transcription factors and various chromatin
remodelers to be in close proximity of one another to target and reorganize the
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chromatin. The SIN3A co-repressor complex is recruited to promoters of several
genes via transcription factors resulting in localized histone deacetylation and
gene silencing (Ayer et al., 1995; Kadosh and Struhl, 1997; Knoepfler and
Eisenman, 1999). Although the SIN3A co-repressor complex can extend its
enzymatic function by interacting with other enzymes such as the ESET histone
methyltransferase (Yang et al., 2003), the complex is commonly referred to as a
co-repressor complex primarily due to its HDAC activity that leads to
transcriptional repression (Bansal et al., 2016).
Interestingly, SIN3A is now being appreciated as a dual regulator of
transcription because SIN3A both activates and represses transcription. For
example, in mouse embryonic stem (ES) cells, Sin3a stimulates Nanog
expression though SOX2 under proliferating conditions (Baltus et al., 2009a).
However, at the same locus, when TP53 recruits SIN3A to the Nanog promoter
during mouse ES cell differentiation, expression of Nanog is suppressed (Lin et
al., 2005). These studies suggest that the SIN3A-co-repressor complex may
differentially regulate a common set of SIN3A target genes depending on the
cellular state (i.e. a proliferative or differentiative state). However, the molecular
mechanisms explaining SIN3A mediated gene activation is so far unknown.
Whether the mechanism is HDAC-dependent or independent is not known. At
the Nanog locus, there is evidence that activation of transcription may be HDACdependent, but the target of the HDAC activity may not involve histones but
rather the transcription factor SOX2. Because the nuclear export and
proteasomal degradation of SOX2 is mediated by acetylation in mouse ES cells
(Baltus et al., 2009b), it is conceivable that the SIN3A-HDAC complex maintains
SOX2 in the deacetylated state in order to retain SOX2 in the nucleus and
sustain the expression of Nanog.
The SIN3A co-repressor complex is not the sole HDAC1/2-containing
complex. Several other HDAC1/2-containing complexes other than the SIN3A
co-repressor have been characterized in mammals. These include the
nucleosome remodeling and deacetylase (NuRD) complex (Denslow and Wade,
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2007), the ES cell specific NANOG and Oct4 (POU5F1) associated deacetylase
(NODE) complex (Liang et al., 2008), the CoREST complex (You et al., 2001),
and the SHIP1 containing complex, which is a testis-specific complex (Choi et al.,
2008). HDAC1/2 are present in large multiprotein complexes mainly because
HDAC1/2 do not bind DNA directly and are likely inactive when they not
incorporated into a complex. The necessity of HDAC1/2 to be integrated into a
complex in order to function was shown for the NuRD complex. In the absence
of MTA2, an interacting member of the NuRD complex, the HDAC enzymatic
activity of the complex was severely compromised (Zhang et al., 1999). This
finding suggests that MTA2 may promote the formation of the catalytic active
histone deacetylase center of the NuRD complex.
With the involvement of HDACs in the establishment of the
transcriptionally repressive state during early embryonic development and the
existence of several HDAC-containing complexes, there is clearly an emerging
question as to which HDAC-containing complex is mediating the development of
the repressive state. This question can be addressed, in part, by assessing each
HDAC-containing complexes’ role in early development and the formation of the
repressive state.
The following work focuses on the SIN3A-co-repressor complex because
SIN3A is essential for mouse development. In this system, zygotic Sin3a
deletion leads to embryonic lethality shortly after implantation (around Embryonic
Day 6.5) (Cowley et al., 2005; Dannenberg et al., 2005). Because crossing
Sin3a heterozygous mice generated the Sin3a null embryos, the experimental
design limited the scope of their observations to zygotic SIN3A and did not
address the role of maternal SIN3A, specifically, the role of SIN3A in the
development of the transcriptionally repressive state.
To investigate the role of maternal SIN3A in the development of the
repressive state during mouse preimplantation development, I utilized a
combined morpholino/small interfering RNA (siRNA) approach to deplete
embryos of maternal SIN3A. This allowed me to assay the contributions of
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maternal SIN3A in a live embryo, and to determine if maternal SIN3A is essential
prior to Embryonic Day 6.5. Because SIN3A has been strongly associated with
the transcriptional regulation of several genes, specifically gene repression, I
hypothesized that depleting mouse embryos of maternal SIN3A would result in a
failure to form the transcriptional repressive state, thereby, affecting the fidelity of
the reprogramming of gene expression during the two-cell stage of mouse
embryonic development. In Chapter 3, I describe our efforts to characterize the
role of maternal SIN3A in the formation of the transcriptionally repressive state. I
show that maternal SIN3A is encoded by a dormant maternal mRNA that is
translationally recruited during oocyte maturation and following fertilization. I also
describe the consequences of inhibiting the maturation-associated increase in
SIN3A in mouse embryos.
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CHAPTER 2: MATERIALS AND METHODS
Oocyte and Embryo Collection, and Embryo Culture and Transfer
Germinal vesicle (GV)-intact oocytes were collected from 6-week-old CF-1
female mice that received an intraperitoneal (IP) injection of 5 IU pregnant mare
serum gonadotropin (eCG, Sigma). Following 44 h of eCG injection, the mice
were killed by CO2 asphyxiation, the ovaries excised and placed in collection
medium. The collection medium used was minimal essential medium (Earle’s
salts) containing gentamicin (10 ug/mL), polyvinylpyrrolidone (3 mg/mL),
pyruvate (100 ug/mL), and 10 mM Hepes, pH 7.21 (MEM/PVP). 10 uM milrinone
was present in the collection medium to maintain meiotic arrest (Tsafriri et al.,
1996). After puncturing the ovaries with 30.5-gauge needles, large preovulatory
follicles were released and collected. The cumulus cells were gently stripped
from cumulus-cell enclosed oocytes (CEOs) using a mouth-operated pipette
(Schultz et al., 1983). Metaphase I (MI) oocytes were collected 7 h after
transferring full-grown oocytes to milrinone-free Chatot Ziomek Brinster (CZB)
medium (Chatot et al., 1989). In vivo metaphase II (MII) eggs were collected
from eCG-primed 6-week old CF-1 female mice 13-16 h following hCG
administration as previously described (Endo et al., 1987). In brief,
superovulated female mice were given an IP injection of 5 IU of eCG, followed 48
h later by 5 IU human chorionic gonadotropin (hCG, Sigma). The superovulated
mice were killed by CO2 asphyxiation 13-16 h after hCG injection, the oviducts
excised, and the eggs obtained by tearing the oviducts with 27.5-gauge needles
in MEM/PVP containing 3 mg/mL hyaluronidase (Sigma). As soon as the
cumulus cells detach from the eggs, the eggs were washed in several drops of
MEM/PVP. In vitro MII eggs were also obtained following maturation in vitro for
16-18 h after transferring full-grown oocytes to milrinone-free CZB medium. Mid
1-cell, late 1-cell, early 2-cell, mid 2-cell, 8-cell and blastocyst stage embryos
were collected from eCG-primed 6-week old CF-1 female mice mated to
B6D2F1/J males (Jackson Laboratory) by flushing either the oviduct or uterus 2017

21, 30-32, 36, 44, 68, 94-96 h post hCG as previously described (Manejwala et
al., 1986). The superovulated females were placed overnight in a cage with a
single male and examined for the presence of a vaginal plug the next morning.
For the mouse embryo transfer experiments, Gfp-/- virgin CF-1 female
mice were mated to Gfp+/- males. The resulting Gfp+/- embryos were collected 18
h after fertilization, and embryos with two distinct pronuclei were microinjected at
19–21 h after fertilization with T7 C-terminal-tagged Sin3a cRNA; controls were
injected with buffer. The embryos were cultured for 96 h (to E4.5) in KSOM
medium as described above at which time the number of blastocysts was scored
and GFP expression assessed. To determine the incidence of implantation of
Sin3a cRNA-injected embryos compared with control embryos, blastocyst stage
embryos were transferred to pseudopregnant female mice on Postcoital Day 3.5
using the Non-Surgical Embryo Transfer Device (Paratechs) according to the
manufacturer’s protocol. Each female received 8-10 embryos, half of which were
injected with Sin3a (Gfp-/- or Gfp+/-) and the other half injected with buffer (Gfp+/or Gfp-/-) to serve as controls. Thus, each female received 4-5 GFP-positive (or
negative) Sin3a cRNA-injected embryos and 4-5 GFP-negative (or positive)
control embryos. The females were killed by CO2 asphyxiation 7 days after
embryo transfer (E10.5), and the presence of GFP expression in the implanted
embryos was assessed.
All animal experiments were approved by the Institutional Animal Use and
Care Committee and were consistent with the National Institutes of Health
guidelines.
Microinjection
Full-grown GV-intact oocytes isolated from CEOs were microinjected with
5 pl of a solution containing 5 µM short interfering RNA (siRNA) and 1 mM
morpholino while being cultured in MEM supplemented with 10 uM milrinone and
20% fetal bovine serum (Kurasawa et al., 1989). The cRNA for Sin3a-T7 and
GFP were injected at 580 ng/µl. The Sin3a (s73784, Ambion) and control
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Luciferase siRNA (D-001100-01-05, Dharmacon) were both injected at a
concentration of 5 µM. The concentration of the Sin3a (5’CCTGGTCATCCAAACGTCGCTTCAT-3’, Gene Tools) and standard control
morpholinos (Gene Tools) was 1 mM.
IVM and IVF
For in vitro maturation (IVM) and in vitro fertilization (IVF), CEOs from 24day-old B6SJLF1/J females primed with eCG for 44 h before isolation were
collected in MEM supplemented with 10 uM milrinone and 20% fetal bovine
serum as previously described (Downs et al., 1986). The cumulus cells were
gently stripped from the CEOs using a mouth-operated pipette. The medium
used for oocyte maturation was MEM supplemented with 0.23 mM pyruvate and
20% fetal bovine serum without milrinone and FSH. The denuded oocytes were
cultured in this medium under drops of mineral oil at 37 °C in 5% O2, 5% CO2
and 90% N2 for 13 -14 h in the presence of 10-15 CEOs as previously described
(Schroeder and Eppig, 1984).
Fertilization of eggs in vitro was performed as previously described
(Hoppe & Pitts, 1973; Schroeder and Eppig, 1984). Sperm suspensions were
obtained from the cauda epididymis of B6SJL males that were at least 4 months
old, and housed individually for at least 3 days. The cauda epididymis were
excised and minced into 0.9 mL of warm equilibrated TYH fertilization medium
supplemented with 4 mg/mL of BSA (Toyoda et al., 1971; Tateno and Kamiguchi,
2007) overlaid with mineral oil. The sperm were allowed to disperse from the
minced epididymis for 5-10 min. The suspension was examined qualitatively for
vigor, and a dilute sample was used to quantify the sperm concentration using a
hemocytometer. The in vitro MII eggs were washed in 4 drops of fertilization
medium and placed into 50 µl drops overlaid with mineral oil. The in vitro MII
eggs were then inseminated using capacitated sperm (5 x 105 sperm/mL)
capacitated for 1.5 h at 37 °C in 5% O2, 5% CO2 and 90% N2. After 3 h of
incubation, the sperm adhering to the eggs were removed using a fine-bore
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mouth-operated pipette, and the inseminated eggs were then transferred to and
cultured in KSOM medium (Erbach et al., 1994; Ho et al., 1995) under mineral oil
at 37°C in 5% O2, 5% CO2 and 90% N2.
Synchronization of 1-cell and 2-cell Embryos
One-cell embryos generated from IVF were cultured in KSOM medium
and examined for the appearance of pronuclei at 1 h intervals starting at 3 h
post-insemination or following the first cleavage at 2 h intervals starting at 19 h
post-insemination. Embryos that formed pronuclei or underwent the first
cleavage within the previous hour were collected and cultured separately. Onecell embryos used for global histone modification immunofluorescence analysis
were fixed 6 h after pronucleus formation. One-cell or 2-cell embryos used for
global transcriptional analysis were added to 2 mM 5-ethynyl uridine (EU) in
KSOM medium from the time the first pronucleus formed until 17 h postinsemination or 12 h post-cleavage for 1 h. Two-cell embryos used for
microarray analysis were collected and frozen 12 h post-cleavage.
Immunofluorescence
Oocyte, MI, egg, or embryo samples were all collected and fixed in 2.5%
paraformaldehyde for 20 min at room temperature within 2 days. The samples
were permeabilized for 15 min in PBS containing 0.1% Triton X-100, washed and
blocked for 30 min with PBS containing 0.1% BSA, 0.01% Tween-20 at room
temperature. Then the cells were incubated with the SIN3A primary antibody
(MBL International) at 1:100 in blocking buffer overnight at 4 °C, followed by
three 15-min washes in blocking solution. After the washes, the samples were
incubated for 1 h with the anti-rabbit cy5-conjugated secondary antibody
(Jackson ImmunoResearch) diluted 1:100 in blocking solution.
In some experiments, 1-cell embryos were first permeabilized for 15 min in
PBS containing 0.1% Triton X-100, washed and then fixed in 2.5%
paraformaldehyde for 20 min at room temperature. The samples were then
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processed as described above.
Polyclonal antibodies against histone H3 acetylated on K18 (39756, Active
Motif, 1:100), histone H4 acetylated on K5 (06-759, Millipore, 1:50), histone H4
acetylated on K8 (06-760, Millipore, 1:100), histone H4 acetylated on K12 (06761, Millipore, 1:100), histone H4 acetylated on K16 (06-762, Millipore, 1:100)
were used to assess histone modifications. Trichostatin A (TSA, Sigma), a
histone deacetylase inhibitor, was used to induce histone hyperacetylation of
early 1-cell embryos by treating the cells with 50 nM TSA for 5 h. Polyclonal
antibody against NANOG (ab80892, Abcam, 1:200), and monoclonal antibodies
against POU5F1/OCT4 (sc-5279, Santa Cruz Biotechnology, 1:100) and CDX2
(MU392A-UC, BioGenex, 1:100) were used to assess these proteins in the
blastocyst. After three 15-min washes with blocking solution, the samples were
incubated with 1 µM SYTOX Green (Molecular Probes) to stain DNA. The cells
were mounted under a coverslip in VECTASHIELD medium (Vector
Laboratories). A Leica TCS SP laser-scanning confocal microscope captured the
images and detected the fluorescence intensity of the samples. For each
experiment, all samples were processed in parallel. For SIN3A, the laser power
was adjusted so that the signal intensity was below saturation for the
developmental stage that showed the highest signal intensity and all images
were then scanned at that laser power. With all the images being scanned at the
same laser power in a developmental series, the signal intensity for SIN3A can
be compared to different developmental stages. The images were processed
and the fluorescence intensity was quantified using ImageJ software (National
Institutes of Health).
Immunoblot Analysis
Protein samples from 40 oocyte, eggs or embryos were solubilized in
Laemmli sample buffer (Laemmli and Quittner, 1974), resolved by SDS-PAGE
(7.5% gel) and transferred to a PVDF membrane. The membrane was blocked
in 2% Amersham ECL prime blocking reagent (GE Healthcare Life Sciences) for
21

1 h and incubated at 4 °C overnight with the primary antibody in blocking
solution. The membrane was then washed four times with PBST (phosphatebuffered saline with 0.1% Tween-20), incubated with a secondary antibody
conjugated with horseradish peroxidase for 1 h in blocking solution and washed
four times with PBST. The signal was detected with the Amersham ECL Select
Western blotting detection reagent (GE Healthcare Life Sciences) according to
the manufacturer’s instructions. The rabbit SIN3A primary antibody (BMP004,
MBL International) was diluted 1:2,000 in blocking solution. The TUBA primary
antibody (T6074, Sigma) was diluted 1:5,000 in blocking solution. The
Amersham ECL secondary antibody (NA934V and NA931V, GE Healthcare Life
Sciences) was diluted 1:75,000 in blocking solution.
Proteasome Inhibition
Mid 1-cell embryos were collected as described above and cultured in
KSOM medium containing either 20 µM MG132 (Sigma), a reversible
proteasome inhibitor (Palombella et al., 1994), or DMSO (Sigma) at 37 °C in 5%
O2, 5% CO2 and 90% N2. After 5 and 10 h of culture, 40 1-cell embryos were
collected from the MG132 group and the DMSO control group at each of the two
time points for immunoblot analysis.
RNA Extraction, RT-PCR and Real-Time PCR
Total RNA from 20 embryos was extracted using the Arcturus PicoPure
RNA Isolation Kit (Life Technologies) according to the manufacturer’s
instructions. However, before the cell extract was added to the purification
column, Gfp cRNA was added to the samples as an external standard. Reverse
transcription reactions were performed using Superscript II reverse transcriptase
(Invitrogen) and random hexamers in a 20 ul reaction volume (Ma and Schultz,
2008). The cDNA was then quantified by quantitative real-time PCR (qRT-PCR)
using the ABI Taqman Assay-on-demand probe/primer sets for Sin3a and GFP
as previously described (Zeng et al., 2004). For each qRT-PCR, one embryo
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equivalent of cDNA was used with a minimum of three replicates as well as a
minus RT and minus template control. Quantification was normalized to GFP.
DNA Replication Assay by BrdUTP Incorporation
Inseminated MII eggs were cultured in KSOM containing 10 µM BrdUTP
either 3 h post-insemination or soon after the first cleavage. One-cell embryos
were fixed 19 h post-insemination and the 2-cell embryos were fixed 34 h postinsemination. The embryos were then processed using the immunofluorescence
protocol described above with the addition of a denaturing step and neutralizing
step after permeabilization. The samples were denatured for 30 min in 2N HCl
and neutralized for 20 min in 100 mM Tris-HCl, pH 8.5 at room temperature.
The samples were incubated with the mouse monoclonal anti-BrdUTP antibody
(11170376001, Roche) at 1:50 in blocking solution overnight at 4 °C. The
samples were incubated with the secondary FITC anti-mouse IgG1 antibody
(1144-02, Southern Biotech) at 1:100 in blocking solution for 1 h. The samples
were mounted in VECTASHIELD medium (Vector Laboratories) containing 2 µM
TO-PRO-3 (Life Technologies).
Global Transcriptional Assay
Click-iT RNA Imaging kit (Invitrogen) was used to assay global
transcription following the manufacturer’s instructions. Briefly, synchronized 2cell embryos were cultured with 2 mM 5-ethynyl uridine (EU) in KSOM medium
for 1 h before fixation in 2.5% paraformaldehyde for 20 min at room temperature.
To assay global transcription in 1-cell embryos, the synchronized embryos were
incubated in KSOM medium containing 2 mM EU from the time the first
pronucleus formed until 17 h post-insemination. After washing and membrane
permeabilization, incorporated EU was detected using the Click-iT detection
molecule. The samples were mounted in VECTASHIELD medium (Vector
Laboratories) containing 2 µM TO-PRO-3 (Life Technologies) to visualize the
DNA. DNA and EU were visualized using a Leica TCS SP laser-scanning
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confocal microscopy. The intensity of the fluorescence was quantified using
ImageJ software (National Institutes of Health) as previously described (Aoki et
al., 1997).
Plasmid DNA Constructs
To generate a T7 C-terminal-tagged Sin3a cRNA, mouse Sin3a coding
sequence was amplified from mouse cDNA clone 6837144 (Thermo Scientific
Open Biosystems) by PCR using the forward primer 5’gaggGCATGCcATGAAGaGgaGacTGGAcGACCA -3’ and the reverse primer 5’gcgGTCGACCCGGCCACGCGTAGGGGCTTTGAATACTGTGCCGTA -3’. After
enzymatic digestion by SphI and SalI-HF, the amplified Sin3a coding sequence
was subcloned into the pIVT-T7 vector to generate pIVT-Sin3a-T7.
Firefly luciferase reporter constructs under the control of the Sin3a 3’
untranslated region (3’ UTR) were generated as previously described (Ma et al.,
2013). Briefly, The entire 1-kb Sin3a 3’ UTR with a ploy(A) site was amplified
using the forward primer 5’-GATATCTAGACTGCAGAGCCAGAGCAGGTAGC-3’
and reverse primer 5’-GCGCCGAATTCACTTATTTCCTTAAGAATCAAGCT-3’.
Amplified Sin3a 3’ UTR were digested by XbaI and EcoRI and subcloned
downstream of the coding sequence of the pIVT-Luc vector.
In Vitro Transcription
The DNA sequence-verified pIVT-Sin3a-T7 construct was linearized by
SfoI digestion. Capped cRNAs were made using in vitro transcription with T7
mMESSAGE mMachine (Ambion) according to the manufacturer’s instructions.
Following in vitro transcription, template plasmid DNAs were digested by adding
RNase-free DNase and the synthesized cRNA were purified by MEGAclear Kit
(Ambion), precipitated and redissolved in RNase-free water.
The DNA sequence verified pIVT-firefly Luc/Sin3a 3’ UTR construct was
linearized by EcoRI digestion. The linearized product was then processed as
described above. For both constructs, a single cRNA band of the expected size
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was observed for each cRNA sample following electrophoresis in an 1%
formaldehyde denaturing agarose gel. Synthesized cRNA was aliquoted and
stored at -80 °C. For microinjection controls, polyadenylated Renilla luciferase
cRNA was generated by using a NotI linearized Renilla luciferase based vector
phRL-SV40 (Promega). The lineralized vector was in vitro transcribed by T7,
and then polyadenylated by Poly(A) Tailing Kit (Ambion) according to the
manufacturer’s instructions. After polyadenylation and electrophoresis on 1%
formaldehyde denaturing agarose gel, it was estimated that approximately a 150
bp poly(A) tail was added to the 3’ terminus of the Renilla Luc cRNA (Ma et al.,
2013).
Luciferase Reporter Assay
Full-grown GV-intact oocytes were microinjected with 5 pl of a solution
containing pIVT-firefly Luc/Sin3a 3’ UTR cRNA (0.365 ug/µl) and control Renilla
Luc cRNA (0.075 ug/µl) (Ma et al., 2013). Injected oocytes were transferred to
milrinone-free CZB medium and matured in vitro for 18 h. Injected GV oocytes
cultured for 18 h in CZB supplemented with 10 uM milrinone served as controls.
In addition to injecting GV full-grown oocytes, MII eggs were microinjected with 5
pl of the same cRNA mixture. Injected MII eggs were activated with 5 mM
strontium chloride in modified CZB medium that is free of Ca2+ and Mg2+ for 6 h
at 37 °C under an atmosphere of 5% CO2 in air. Injected MII eggs cultured in
Ca2+- and Mg2+ -free CZB medium without SrCl2 for 6 h served as controls.
Luciferase activity was assayed by lysing oocytes/eggs/embryos in 1x passive
lysis buffer and analyzed using a dual-luciferase reporter assay system
(Promega) according to the manufacturer’s instructions. For signal
normalization, the background firefly/Renilla luciferase activity readout from
noninjected oocytes/eggs was subtracted, and the firefly luciferase activity was
normalized to that of the coinjected Renilla luciferase reporter.
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Microarrays Analysis
Total RNA was extracted from 20 oocytes/synchronized 2-cell embryos as
described above and amplified with the Ovation Pico WTA system V2 (NUGen).
The product was then fragmented and labeled with the Encore Biotin Module V2
(NuGen). Four independent biological replicates were hybridized to GeneChip
Mouse 2.0 ST microarrays (Affymetrix, Sata Clara, CA, USA).
The microarray datasets from the MoGene-2_0-st (GPL16570) platform
were processed using the Oligo package (Carvalho and Irizarry, 2010) from the
Bioconductor framework (Gentleman et al., 2004). Raw data was background
corrected, normalized and summarized using the robust multi-array average
procedure.
Differential expression analysis was done using a robust linear model with
empirical Bayes from the limma package (Ritchie et al., 2015). We compared the
following conditions: α-amanitin vs. control 2-cell embryo; Sin3a KD (knockdown)
2- cell embryo vs. control 2-cell embryo; control 2-cell embryo vs. GV oocyte; and
Sin3a KD 2-cell embryo vs. GV oocyte. The P-values were calculated using a
moderate t-statistic. The calculated P-values were adjusted for multiple testing
using the false discovery rate procedure. Genes were marked as differentially
expressed if they had a minimal absolute fold-change >1.5 and a calculated Pvalue <0.05.
Platform annotations were downloaded from the Gene Expression
Omnibus repository, and all genes that mapped to differentially expressed
Affymetrix probesets (defined as false discovery rate <0.05 and absolute
logarithmic fold-change >0.58, in any of the comparisons), were kept for further
analysis. The 29,680 Affymetrix probesets, which could be annotated, were used
for the differential expression analysis, and functional analysis of differentially
expressed gene sets was done using the pantherdb database (Mi et al., 2013).
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Statistical Analysis
One-way ANOVA were used to evaluate the differences between groups
using GraphPad Prism 6 software (GraphPad Software). A level of P-value <
0.05 was considered to be significant.
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CHAPTER 3: INHIBITING THE MATURATION-ASSOCIATED INCREASE IN
MATERNAL SIN3A IMPAIRS THE REPORGRAMMING OF GENE
EXPRESSION DURING MOUSE PREIMPLANTATION DEVELOPMENT

Research presented in this chapter was carried out in collaboration with the
laboratory of Monica Mainigi and Kristian Vlahoviček/Petr Svoboda. Total RNA
extraction, amplification, fragmentation and labeling for microarray analysis were
performed by Jun Ma, a postdoctoral fellow in the Schultz laboratory. Microarray
analysis was performed by Vedran Franke, a doctoral student in the Kristian
Vlahoviček laboratory. Olga Davydenko, a postdoctoral fellow in the Mainigi
laboratory, performed the embryo transfer experiments.
This work was originally published in Biology of Reproduction. Richard Jimenez,
Eduardo O. Melo, Olga Davydenko, Jun Ma, Monica Maingi, Vedran Franke, and
Richard M. Schultz. Maternal SIN3A regulates reprogramming of gene
expression during mouse preimplantation development. Biology of
Reproduction. 2015. 93(4): 89, 1-12.
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3.1 Results
3.1a Sin3a is a dormant maternal mRNA that is recruited for translation
during oocyte maturation and following fertilization
To gain a sense of when the Sin3a gene could be functioning, we
analyzed the temporal pattern of Sin3a abundance by qRT-PCR using random
hexamers in mouse oocytes and embryos. The observed differences in relative
abundance between the different stages of development will unlikely be
attributed to changes in the length of the poly (A) tail of Sin3a because random
hexamers were used for cDNA synthesis. As with many maternal mRNAs that
are degraded during oocyte maturation (Su et al., 2007), Sin3a was highly
expressed in the full-grown GV intact-oocyte and was degraded upon oocyte
maturation as evidenced by the decrease in relative abundance. Sin3a
abundance reached its lowest level by the 8-cell stage, and between the 8-cell
and blastocyst stage,its abundance increased, presumably due to zygotic
transcription (Fig. 3.1A). Interestingly, immunoblot analysis of the SIN3A protein
revealed a small amount of SIN3A protein present in the full-grown GV-intact
oocyte, even though there was an abundant amount of Sin3a transcript present
at this stage. The amount of SIN3A protein dramatically increased between MI
and MII and a further increase was observed following fertilization before a
dramatic and rapid loss of SIN3A protein by the 2-cell stage (Fig. 3.1B). The
lowest relative abundance of SIN3A protein was observed at the 8-cell stage and
then increased by the blastocyst stage, which is consistent with Sin3a mRNA
relative abundance. It is also noteworthy that this increase in the amount of
Sin3a transcript and protein by the blastocyst stage nearly coincides with the
stage at which Sin3a embryonic null embryos (born from Sin3a+/- intercrosses)
perish.
To better characterize the time course of maternal SIN3A protein loss
during early embryonic development, 1-cell and 2-cell mouse embryos were
collected for immunoblot analysis. The results showed that the dramatic
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reduction in the amount of SIN3A protein occurred as early as the late 1-cell
stage (~63% SIN3A loss compared to the mid 1-cell), and continued to the early
2-cell stage (~ 87% SIN3A loss compared to the late 1-cell) and late 2-cell stage,
where SIN3A was faintly detected by immunoblot analysis (Fig. 3.2). Exposure
of the embryos to MG132, a proteasome inhibitor, significantly inhibited the
reduction in the amount of SIN3A protein, suggesting that the loss of maternal
SIN3A protein is potentially mediated by the proteasome (Fig. 3.3).
Immunocytochemical detection of SIN3A protein revealed that the SIN3A
protein was nuclear, present in both pronuclei at the 1-cell stage, present in the
nuclei of both the TE and ICM cells at the blastocyst stage, and had a similar
pattern of expression as revealed by immunoblot analysis (Fig. 3.4). The
localization of the SIN3A protein remained nuclear in the male and female
pronuclei even after the 1-cell mouse embryos were permeabilized prior to
fixation (Fig. 3.5), indicating that the SIN3A protein is likely associated with the
chromatin in both pronuclei.
The results described above indicate that Sin3a is a dormant maternal
mRNA that is recruited for translation during oocyte maturation and following
fertilization. In mouse, recruitment of transcripts for translation during oocyte
maturation is driven by sequences within the 3’ untranslated region (3’ UTR) of
their respective transcripts, e.g., cytoplasmic polyadenlyation elements (CPEs)
(Oh et al., 2000). Given the increase in the relative abundance of SIN3A protein
between the full-grown GV-intact oocyte and the MII egg and the presence of
CPEs within the 3’ UTR of the Sin3a transcript, we measured the luciferase
activity of lysed MII eggs following maturation of full-grown GV-intact oocyte
microinjected with firefly luciferase reporter cRNA under the control of the Sin3a
3’ UTR. This experiment revealed a dramatic increase in luciferase activity
following maturation of oocytes microinjected with the luciferase reporter cRNA
(Fig. 3.6A). An increase in luciferase activity following microinjection of the cRNA
and later activation of MII eggs was also observed (Fig. 3.6B), which is
consistent with the observed increase in the relative abundance of the SIN3A
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protein following fertilization.
3.1b Inhibiting the maturation-associated increase in SIN3A alters global H3
and H4 histone acetylation in 1-cell embryos
Because SIN3A is a part of the SIN3A-co-repressor complex and the
results described above suggesting that the function of SIN3A is restricted mainly
to the 1-cell stage, we wanted to assess whether the loss of maternally recruited
SIN3A had an effect on histone acetylation at the 1-cell stage. We utilized a
combined morpholino/siRNA approach to inhibit the oocyte maturationassociated increase in SIN3A. Following oocyte maturation of full-grown GVintact oocytes microinjected with the morpholino/siRNA sample targeted against
the Sin3a transcript, no increase in the amount of SIN3A protein was seen (Fig.
3.7). As a control, when a scramble siRNA and a standard morpholino were
injected into the full-grown oocyte, a normal maturation-associated increase in
SIN3A was observed (Fig. 3.7). These results show that this approach can
effectively inhibit the maturation-associated increase in SIN3A.
Because the epigenetic modifications of the male and female genomes
are distinct at fertilization and during the first cell cycle of early embryo
development as described above (Santos et al., 2005; Erhardt et al., 2003;
Lepikhov and Walter, 2004; Liu et al., 2004) and the results above suggest that
SIN3A is chromatin-associated in both male and female pronuclei (Fig. 3.5), it is
plausible that SIN3A may have differential effects on the chromatin of each
pronuclei. To determine if the inhibition of the maturation-associated increase in
SIN3A affected global histone acetylation in 1-cell embryos and to determine if
the effects were dependent on the parental origin of the chromatin, we performed
immunocytochemistry analysis of 1-cell embryos generated by in vitro
insemination of in vitro matured, microinjected oocytes rather than activation of
the oocytes. Also, because in vitro insemination results in asynchronous 1-cell
embryo formation due to differences in the timing of fertilization and because the
appearance of histone post-translation modifications during the 1-cell stage is
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dependent on the stage of pronuclear development, highly synchronized 1-cell
embryos were used for immunocytochemistry analysis to minimize cell-cycle
differences.
We assessed global H3K18ac, H4K5ac, H4K8ac, H4K12ac and H4K16ac
in highly synchronized 1-cell embryos because many of these marks are affected
in mouse embryos when HDAC function is perturbed (Ma and Schultz, 2008) and
because these histone modifications represent three distinct regions of genes;
H3K18ac is enriched in the region surrounding the transcriptional start site,
whereas the others are enriched in the promoter and transcribed regions of
active genes (Wang et al., 2008). Interestingly, the enrichment of H4K12ac in
transcribed regions is associated with transcriptional elongation (Cho et al.,
1998). Although a moderate hyperactylation of all these marks globally was
observed when 1-cell embryos were incubated in the presence of Trichostatin A,
an HDAC inhibitor, such was not the case when the maturation-associated
increase in SIN3A was inhibited (Fig. 3.8). Surprisingly, we observed a modest
hypoacetylation for global H3K18ac, H4K8ac and H4K12ac.
3.1c Inhibiting the maturation-associated increase in SIN3A impairs
development beyond the 2-cell stage
Next, we assessed the effect of inhibiting the maturation-associated
increase in SIN3A on preimplantation development. After blocking the
maturation associated-increase in SIN3A, the embryos depleted of maternally
recruited SIN3A developed poorly beyond the 2-cell stage when compared to the
control-injected embryos (Fig. 3.9). The deleterious effects on development of
subjecting denuded, microinjected oocytes to in vitro maturation and
insemination is the likely explanation for the low incidence of development in the
control group. The arrest at the 1-cell and 2-cell stages in the experimental
group is unlikely due to a failure to undergo DNA replication because essentially
all of the experimental and control embryos at both the 1-cell and 2-cell stages
incorporated BrdU, and based on comparable signal intensities of BrdU
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incorporation, each group replicated their DNA to a similar extent (Fig. 3.10).
In mice, impairment of ZGA and a reduction in transcription by at least
70% by α-amanitin leads to developmental arrest at the 2-cell stage (Flach et al.,
1982; Bolton et al., 1984; Schultz, 1993; Ma et al., 2001). To determine whether
the developmental arrest observed was due to inhibiting transcription at a global
level, we assessed global transcription by EU incorporation after inhibiting the
maturation-associated increase in SIN3A in highly synchronized 2-cell embryos.
We observed that transcription was reduced by 50% in the experimental 2-cell
embryos when compared to the control 2-cell embryos (Fig. 3.11). It is unlikely
that the developmental arrest at the 2-cell stage was due to inhibiting global
transcription because a 50% reduction in transcription is not sufficient to lead to a
developmental arrest at the 2-cell stage.
Because transcription in 1-cell embryos is required for development
beyond the 2-cell stage but is dispensable for cleavage to the 2-cell stage (Abe
et al., 2015), we assessed global transcription by EU incorporation in 1-cell
embryos. No effect on transcription in either the maternal or paternal pronucleus
of 1-cell embryos was observed after blocking the maturation-associated
increase in SIN3A (Fig. 3.12).
3.1d Impairment of gene expression reprogramming in maternal SIN3Adepleted embryos
In mice, a dramatic reprogramming of gene expression accompanies ZGA
during the 2-cell stage and failure to successfully reprogramming the genome is
associated with a developmental arrest at the 2-cell stage (Bultman et al., 2006).
To examine whether the reprogramming of gene expression was affected, we
carried out genome-wide expression profiling of control full-grown GV-intact
oocytes, highly synchronized control and maternal SIN3A-depleted 2-cell
embryos cultured with or without the transcriptional inhibitor α-amanitin.
Because SIN3A regulates expression of its target genes, we expected that a
subset of zygotically activated genes would be affected in 2-cell embryos. The
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zygotically activated genes are genes whose expression is inhibited by αamanitin.
As expected, hierarchical cluster analysis did not reveal significant
differences between the transcriptomes of the full-grown GV intact-oocytes and
2-cell embryos treated with α-amanitin (Fig. 3.13). However, the transcriptomes
of both these groups differed significantly from the transcriptomes of the control
and experimental 2-cell embryos. Importantly, the transcriptomes of the control
and maternal SIN3A-depleted 2-cell embryos differed significantly from each
other, which is consistent with the prediction that a subset of zygotically activated
genes would be impaired when maternal SIN3A is depleted from the embryo.
Because formation of a histone hyperacetylation responsive
transcriptionally repressive state may decrease expression of inappropriately
activated genes and because SIN3A may have a role in formation of the
repressive state, we identified zygotically activated genes whose expression was
higher in maternal SIN3A-depleted embryos. We found 145 zygotically
expressed genes whose expression was at least 1.5-fold higher in 2-cell embryos
derived from eggs in which the maturation-associated increase in SIN3A was
inhibited (Table 3.1). Not only were protein-coding genes included in the list of
145 genes, but ribosomal genes, small nuclear RNAs, and noncoding RNAs
were also present.
Because formation of a transcriptionally repressive state may also
terminate expression of inappropriately activated genes in mouse 2-cell embryos,
it is likely that genes, which were not normally zygotically activated in 2-cell
embryos, were now inappropriately expressed in 2-cell embryos depleted of
maternal SIN3A. These genes would show no difference in expression between
control and α-amanitin-treated 2-cell embryos, but would show an increased
expression in maternal SIN3A-depleted embryos when compared to control
embryos. We found 98 genes that were not zygotically activated in 2-cell
embryos, but whose expression was increased in maternal SIN3A-depleted 2-cell
embryos (Table 3.2). These genes included protein coding genes, ribosomal
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genes, small nuclear RNAs, noncoding RNAs, small nucleolar RNAs, and
microRNAs. The qRT-PCR on four transcripts from each class whose
expression was increased by inhibiting the maturation-associated increase in
SIN3A revealed changes in relative transcript abundance similar to that observed
from the microarray data for all of them except for one (Table 3.3). These results
afford confidence that differences observed in the microarray data analysis
reflect changes in relative transcript abundance.
To determine if the dysregulated genes identified in the 2-cell embryos
depleted of maternal SIN3A form gene clusters, the genes whose expression
was increased in maternal SIN3A-depleted embryos were mapped to
chromosomes. As expected, the misexpressed genes mapped within
chromosomal gene clusters, with enrichment of these genes on some
chromosomes (e.g., chromosome 11 and 12) (Fig. 3.14).
3.1e Exogenously expressing SIN3A beyond the 1-cell stage does not
impair preimplantation development
The restricted presence of maternal SIN3A protein mainly to the 1-cell
stage is unique because other maternal proteins that are encoded by dormant
maternal mRNAs are present for much longer periods of time. It is likely that
restricting the function of maternal SIN3A mainly to the 1-cell stage and the
precipitous reduction in the amount of SIN3A protein are required for
development beyond the 2-cell stage. Accordingly, we assessed the effect of
maintaining the presence of SIN3A beyond the 1-cell stage. After microinjecting
cRNA encoding Sin3a into 1-cell mouse embryos at different concentrations, we
identified the conditions that allowed for an increase in the amount of SIN3A
protein in 2-cell embryos to an amount that is comparable to that observed
following oocyte maturation and fertilization (Fig. 3.15A).
Because SIN3A protein is not stable during mouse preimplantation
development, we decided to use 1-cell embryos microinjected with a buffer as
the control group because a typical control would involve microinjecting a cRNA
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encoding some protein that is usually stable, which SIN3A is not. Furthermore,
we observed that the developmental incidence to the blastocyst stage depended
on what control cRNA was microinjected (Fig. 3.15C). Results from these
experiments showed that development to the blastocyst stage was not affected
by maintaining the presence of SIN3A protein beyond the time when it has
normally decreased to undetectable levels (Fig. 3.15B). In addition, total cell
numbers and their types (epiblast, ICM, trophectoderm) in blastocysts were not
affected (Fig. 3.16). Furthermore, the blastocysts from microinjected 1-cell
embryos that maintained elevated levels of SIN3A protein beyond the 1-cell
stage had a similar incidence of implantation and resorption as the control groups
when embryo transfer experiments were performed (Fig. 3.17).
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Figure 3.1. Developmental expression profile of Sin3a/SIN3A.
(A) Sin3a mRNA levels were measured by quantitative RT-PCR at the indicated
stages. Data were normalized against the detected levels of exogenously added
GFP and expressed relative to the value obtained for mid 1-cell embryos. The
experiment was conducted three times and the data are expressed as mean ±
SEM. GV, full-grown GV-intact oocytes; MII, metaphase II-arrested egg; 1C, 2C,
and 8C refer to 1-cell, 2-cell, and 8-cell stages, respectively; BL, blastocyst. (B)
The relative amount of SIN3A was measured by immunoblot analysis. MII in
vitro, oocytes were matured in vitro to MII; MII in vivo, MII eggs were collected
following maturation in vivo. The TUBA signal was used to normalize total
protein loading. The experiment was performed three times and similar results
were obtained in each case. A representative example is shown.
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Figure 3.2. Time course for SIN3A protein loss.
(A) Immunoblot analysis for SIN3A was conducted at the indicated
developmental stages. The TUBA signal was used to normalize total protein
loading. The experiment was performed three times and similar results were
obtained in each case; shown is a representative example. (B) Quantification of
the data shown in A. The data are expressed as the mean ± SEM and the
SIN3A signal is relative to the mid 1-cell embryo.
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Figure 3.3. SIN3A protein loss is proteasome-dependent
(A) Mid 1-cell embryos were isolated and cultured in vitro in the presence of the
proteasome inhibitor MG132 or DMSO, the vehicle. SIN3A protein abundance
was measured by immunoblot analysis at the indicated times. The TUBA protein
signal was used to normalize total protein loading. The experiment was
performed three times and a representative example is shown. (B)
Quantification of the data shown in A. The data are expressed as the mean ±
SEM and the SIN3A signal is relative to the mid 1-cell embryo. The times refer to
the number of hours post-hCG injection. * P < 0.05.
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Figure 3.4. Developmental expression profile of SIN3A protein by
immunocytochemistry.
Immunocytochemical analysis of SIN3A expression during preimplantation
development. The experiment was conducted two times, and at least 15
oocytes/embryos were analyzed for each experiment.
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Figure 3.5. Similiar amount of chromatin-associated SIN3A protein between
male and female pronuclei.
Immunocytochemical detection of chromatin-associated SIN3A was performed
by permeabilizing and then fixing 1-cell embryos and the signal was then
compared to the signal obtained when the 1-cell embryos were fixed and then
permeablized. Shown are representative images in which there is no obvious
difference for the two different protocols.
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Figure 3.6. Sin3a 3’UTR contains elements that drive translational
recruitment during oocyte maturation and following activation.
Full-grown oocytes (A) or MII eggs (B) were microinjected with the luciferase
reporter cRNAs. Firefly luciferase reporter activities were normalized to the coinjected Renilla luciferase. The data are expressed as mean ± SEM, and at least
10 oocytes/embryos were analyzed for each group.
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Figure 3.7. Combined Sin3a morpholino and siRNA inhibit maturationassociated increase in the amount of SIN3A protein.
(A) Full-grown oocytes microinjected with control or Sin3a morpholino (MO) and
siRNA were cultured for 1 h in medium containing 2.5 µM milrinone and then
cultured in inhibitor-free medium for maturation. MII eggs were collected 16 h
after maturation and used for immunoblot analysis to detect SIN3A protein levels.
TUBA was used to normalize total protein loading. The experiment was
performed three times and a representative example is shown. (B)
Quantification of the relative amount of SIN3A shown in panel A. The data are
expressed as mean ± SEM.
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Figure 3.8. Effect of inhibiting the maturation-associated increase in SIN3A
on histone acetylation in 1-cell embryos.
(A) The indicated histone were assayed by immunocytochemistry for their
acetylation status using maternal-SIN3A depleted 1-cell embryos, control 1-cell
embryos, and 1-cell embryos that were incubated with Trichostatin A (an HDAC
inhibitor) to generate the maximum increase in histone acetylation. The
experiment was performed two times and at least a total of 10 embryos were
analyzed for each sample group. (B) Quantification of the data shown in panel
A. The data are expressed relative to the control 1-cell embryos and are
expressed as mean ± SEM. *, p < 0.05.
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Figure 3.9. Inhibiting the maturation-associated increase in SIN3A protein
leads to a developmental arrest at the 2-cell stage.
After inhibiting the maturation-associated increase in SIN3A protein, the
maternal-SIN3A depleted and control MII eggs were in vitro fertilized (IVF) and
embryo development was assessed at 24, 48 and 72 h after fertilization. The
experiment was performed three times and the data pooled. A total of 56
experimental and 43 control embryos were analyzed. hpf, hours postfertilization.
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Figure 3.10. DNA replication is not inhibited in 1- and 2-cell embryos when
the maturation-associated increase in SIN3A protein is inhibited.
After inhibiting the maturation-associated increase in SIN3A protein, the
maternal-SIN3A depleted and control MII eggs were in vitro fertilized (IVF) and
placed in medium containing BrdU, a deoxyribonucleotide analog incorporated
into DNA. Controls were injected with control siRNA and morpholino. BrdU
incorporation was assayed by immunocytochemistry in 1-cell and 2-cell embryos.
The experiment was conducted two times, and at least 10 embryos were
analyzed for each experiment.
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Figure 3.11. Transcription is reduced in 2-cell embryos depleted of
maternal-SIN3A.
(A) After inhibiting the maturation-associated increase in SIN3A protein, the
maternal-SIN3A depleted and control MII eggs were in vitro fertilized (IVF) and
placed in medium containing EU, a ribonucleotide is incorporated into nacent
RNA. Controls were injected with control siRNA and morpholino. EU
incorporation was assayed by immunocytochemistry in 2-cell embryos. The
experiment was performed 4 times and shown are representative images. At
least 10 embryos were analyzed for each treatment group. (B) Quantification of
the images shown in panel A. The data are expressed as mean ± SEM. * p <
0.05.
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Figure 3.12. No change in global transcription at the 1-cell stage when the
maturation-associated increase in maternal SIN3A is inhibited.
(A) Immunocytochemical detection of EU incoportation in maternal-SIN3A
depleted and control 1-cell embryos. Shown are representative images. The
experiment was conducted two times, and at least 10 embryos were analyzed for
each experiment. (B) Quantification of the data shown in panel A. The data are
expressed as mean ± SEM.
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Figure 3.13. Heat map of all samples from different treatment groups
constructed using hierarchical clustering.
Replicate sample numbers are indicated at the bottom of the figure. GV, fullgrown GV-intact oocytes; a-am, 1-cell embryos incubated in α-amanitin to the 2cell stage; 2C, 2-cell embryos derived from oocytes injected with control siRNA
and morpholino matured and fertilized in vitro; KD, 2-cell embryos derived from
oocytes injected with Sin3a siRNA and morpholino matured and fertilized in vitro.
Colors correspond to relative RNA abundance (on the log2 scale) for the
detected genes each of which is represented by one horizontal bar. The
numbers correspond to each replicate within each group.
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Figure 3.14 Karyogram of genes whose expression was elevated in 2-cell
embryos depleted of maternal SIN3A (left panel) and density of genes (right
panel).
The comparison showed that most of the SIN3A sensitive genes emanated from
gene dense regions.
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Figure 3.15. Over-expressing SIN3A does not affect pre-implantation
development.
(A) One-cell embryos were microinjected with cRNA encoding Sin3a and were
cultured to the 2-cell stage and used for immunoblot analysis to detect SIN3A
protein levels. Control embryos were injected with buffer. TUBB was used to
normalize total protein loading. The experiment was performed three times and
a representative example is shown. (B) Effect of over-expressing SIN3A on
development to the blastocyst stage. Control embryos were injected with buffer.
The experiment was conducted 7 times and at least 261 embryos were analyzed
in each group. The data are expressed as mean ± SEM. (C) One-cell embryos
were microinjected with either a cRNA encoding Sin3a, a cRNA encoding
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mCherry, Gfp, or Luc, or buffer. The incidence of development to the blastocyst
was then assessed. The experiment was performed 4 times using the mCherry
control with at least 85 embryos examined for each treatment group, 15 times
using the GFP control with at least 292 embryos examined for each treatment
group, 2 times using the Luciferase control (ctrl) with at least 76 embryos
examined for each treatment group, and 7 times using the buffer control with at
least 261 embryos examined for each treatment group. The data are expressed
as mean ± SEM. *P <0.05; **P < 0.01.
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Figure 3.16. Over-expressing SIN3A does not affect cell numbers in
blastocysts.
(A) Effect of over-expressing SIN3A on cell numbers in blastocysts. The
experiment was conducted 4 times and at least 32 embryos were analyzed in
each group. The data are expressed as mean ± SEM. (B) Immunocytochemical
detection of lineage markers in blastocysts derived from embryos overexpressing SIN3A.
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Figure 3.17. Over-expressing SIN3A does not affect pre-implantation
development.
One-cell embryos were microinjected with cRNA encoding Sin3a or buffer and
were cultured to the blastocyst stage. The incidence of post-implantation
development following blastocyst transfer of control and SIN3A-over-expressing
embryos was then assessed. The experiment was conducted 6 times.
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Table 3.1. Zygotically expressed genes whose expression is up-regulated
following inhibition of the maturation-associated increase in SIN3A.
Annotation
ID

17375409

SPOT ID
chr5(-):2367428923674381
chr3(+):4099269340992850
chr7(+):110627661110629819
chr12(+):7428427674295950
chr17(-):3495201334952075
chr9(+):9842296198446551
chr11(+):4979415549838620
chr9(+):5476474854773110
chr16(+):9122555091228677
chr4(+):8879957588801130
chr9(+):5049452550505639
chr12(+):109643748109643818
chr2(+):127363208127367221
chr1(+):164249046164265385
chr18(-):7493932274961263
chr3(-):145646971145649985
chr1(+):4269714642700210
chr8(-):7247799572492614
chr7(-):4963149949636849
chr8(-):8466133184662852
chr2(+):122298900122302885

17362121

chr19(-):6922426-6925380

17446058
17397331
17481770
17276375
17344122
17520624
17249036
17517416
17327030
17415345
17517097
17278767
17375880
17218889
17355443
17410974
17212313
17510563
17491396
17511130

Gene name

Biotype

5S_rRNA

rRNA

U1

snRNA

Adm

protein_coding

1700086L19Rik

protein_coding

1110038B12Rik

processed_transcript

Rbp1

protein_coding

Gfpt2

protein_coding

Crabp1

protein_coding

Olig2

protein_coding

Gm13285

protein_coding

1600029D21Rik

protein_coding

SNORD113

snoRNA

Adra2b

protein_coding

Slc19a2

protein_coding

Lipg

protein_coding

Cyr61

protein_coding

Pou3f3

protein_coding

Slc35e1

protein_coding

Dbx1

protein_coding

Ier2

protein_coding

Duoxa1

protein_coding

1700019N12Rik

protein_coding
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17302483
17279509
17312829
17497847
17418154
17263511
17322125
17237186
17292011
17239664
17308939
17386477
17395373
17397523
17406363
17288898
17394175
17411961
17345293
17218321
17289372
17368171
17270053
17310982
17470060
17394153

chr14(+):103070216103077630
chr12(+):113152012113153879
chr15(+):7892672578930465
chr7(-):141278331141279133
chr4(+):123116248123118000
chr11(-):5996318159964944
chr15(-):102028228102029513
chr10(+):110745439110787384
chr13(-):4071567540733823
chr10(-):2112493021160984
chr14(-):7976677279771312
chr2(-):7297154872986716
chr2(-):177197202177200415
chr3(+):5346366653481755
chr3(-):8444219684480439
chr13(+):8165780681671899
chr2(-):164424247164443887
chr4(+):1526582015286753
chr17(-):4601699346032377
chr1(+):153740349153745468
chr13(+):9724110597253040
chr2(+):2570687925707721
chr11(-):102106676102107832
chr15(+):3529609835303305
chr6(-):116633008116673836
chr2(-):164354070164389095

Cln5

protein_coding

Crip1

protein_coding

Lgals1

protein_coding

Sct

protein_coding

Oxct2b

protein_coding

Rasd1

protein_coding

Krt18

protein_coding

E2f7

protein_coding

Tcfap2a

protein_coding

Myb

protein_coding

Pcdh8

protein_coding

Gm11084

protein_coding

Gm14391

protein_coding

2810046L04Rik

protein_coding

Fhdc1

protein_coding

Lysmd3

protein_coding

Sdc4

protein_coding

Tmem64

protein_coding

Vegfa

protein_coding

Rgs16

protein_coding

Enc1

protein_coding

A230005M16Rik

processed_transcript

Pyy

protein_coding

Osr2

protein_coding

Rassf4

protein_coding

Slpi

protein_coding
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17261542
17468018
17393764
17291525
17317313
17544469
17399986
17265470
17240077
17544816
17315245
17455936
17500068
17515617
17348400
17415319
17312032
17535535
17305709
17480620
17303496
17260474
17438419
17534051
17510136
17367856
17437049

chr11(-):3311743033147400
chr6(-):8272502582774454
chr2(-):157562361157562447
chr13(-):2894891928953713
chr15(-):5889015358933730
chrX(-):134460116134476490
chr3(+):9344233093449077
chr11(-):7103194171033617
chr10(-):3083235930842801
chrX(-):137115397137122083
chr15(+):102028216102032026

Fgf18

protein_coding

Hk2

protein_coding

Nnat

protein_coding

Sox4

protein_coding

Tatdn1

protein_coding

Taf7l

protein_coding

Tchh

protein_coding

6330403K07Rik

processed_transcript

Hey2

protein_coding

Esx1

protein_coding

Krt18

protein_coding

chr6(+):6863334-6868568
chr8(+):2341150223449632
chr9(+):2729922827334763
chr18(+):1105251011085635
chr4(+):8878213188783592
chr15(+):6692960766931107
chrX(+):7334262073359080
chr14(-):4638352046390669
chr7(+):100006404100034728
chr14(-):1234189212345865

Dlx6

protein_coding

Sfrp1

protein_coding

Igsf9b

protein_coding

Gata6

protein_coding

Ifnz

protein_coding

Ndrg1

protein_coding

Zfp275

protein_coding

Bmp4

protein_coding

Chrdl2

protein_coding

Fezf2

protein_coding

chr11(-):7206086-7213923
chr5(+):7692836876947758
chrX(+):3611211036171262
chr8(-):7076277370767151
chr2(+):2520862325208727
chr5(+):3782056437822751

Igfbp3

protein_coding

2310040G07Rik

processed_transcript

Il13ra1

protein_coding

Ifi30

protein_coding

U6

snRNA

Msx1

protein_coding
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17439942
17460634
17227259
17259235
17484601
17488458
17287361
17360216
17529307
17323192
17295130
17489399
17335467
17273447
17410809
17482095
17479834
17483258
17255352
17417622
17286231
17402144
17388353
17544919
17344114
17505260

chr5(+):105876565105915885
chr6(+):8819389188207032
chr1(-):135150666135150766
chr11(+):119942763120006782
chr7(+):140835018140837968
chr7(-):2837678428379255
chr13(+):5184667551848475
chr19(+):4785497047864790
chr9(-):8377869283806305
chr16(+):1470585214709395
chr13(-):9560178995618459
chr7(-):3103272231042481
chr17(+):2909097929100722
chr11(-):121053423121063569
chr3(-):144188530144205255
chr7(+):116504374116540588
chr7(+):8286733382871576
chr7(+):127244526127254803
chr11(+):9512008995125296
chr4(+):117096075117115383
chr13(+):2894304828951671
chr3(+):120683970120693602
chr2(-):9236504692371057
chrX(-):140006805140062712
chr17(-):3495023534952471
chr8(+):107293470107379907

Zfp326

protein_coding

Gata2

protein_coding

5S_rRNA

rRNA

Baiap2

protein_coding

1190003J15Rik

protein_coding

Zfp36

protein_coding

Gadd45g

protein_coding

Gsto1

protein_coding

Elovl4

protein_coding

Snai2

protein_coding

F2r

protein_coding

Fxyd5

protein_coding

Cdkn1a

protein_coding

Sectm1b

protein_coding

Lmo4

protein_coding

Nucb2

protein_coding

Mex3b

protein_coding

Zfp771

protein_coding

Dlx3

protein_coding

Ptch2

protein_coding

Sox4

protein_coding

Usp12

protein_coding

Gyltl1b

protein_coding

Nup62cl

protein_coding

1110038B12Rik

processed_transcript

Nfat5

protein_coding
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17321307
17473985
17376541
17544786
17464706
17491378
17400250
17522876
17322113
17297750
17537895
17319607
17484454
17535353
17536969
17447610
17380766
17396492
17359088
17544689
17251500
17458592
17330905
17448712
17512086
17456131
17321474

chr15(-):9866342198677461
chr7(+):1569210115693156
chr2(+):131909928131938431
chrX(-):136954988136976874
chr6(-):6877805-6882085
chr7(-):4886642948881596
chr3(+):9516045795174024
chr9(+):118478189118486132
chr15(-):101996711102004342
chr14(+):2569417025700468
chrX(+):136270253136271978
chr15(-):8232953282338826
chr7(+):139943789139945112
chrX(+):7166366771669257
chrX(+):103414467103424583
chr5(-):3782048537824585
chr2(+):180456245180474867
chr3(+):2878131128798846
chr19(+):3769780837701536
chrX(-):135844275135844731
chr11(+):6905977569061576
chr6(+):5215690252162289
chr16(-):5071929750732773
chr5(-):7275571872868459
chr8(-):9575695095757084
chr6(+):1706514917105828
chr15(-):9894984198953551

Rnd1

protein_coding

NA

NA

Prnd

protein_coding

Tmsb15b1

protein_coding

Dlx5

protein_coding

E2f8

protein_coding

Sema6c

protein_coding

Eomes

protein_coding

Krt8

protein_coding

Ppif

protein_coding

Ngfrap1

protein_coding

Naga

protein_coding

Utf1

protein_coding

Gpr50

protein_coding

Tsx

protein_coding

Msx1

protein_coding

Slco4a1

protein_coding

Eif5a2

protein_coding

Cyp26a1

protein_coding

Gprasp2

protein_coding

9330160F10Rik

protein_coding

Gm15051

processed_transcript

5330426P16Rik

protein_coding

Tec

protein_coding

SNORA76

snoRNA

Tes

protein_coding

Tuba1a

protein_coding
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17536428
17231694
17232912
17427312
17276814
17315718
17537839
17536848
17432488
17389456
17340609
17437558
17429954
17415323
17451816
17415333
17379224

chrX(+):9707259697082104
chr10(+):1309069113131694
chr10(+):4181057441908436
chr4(-):9504903495052222
chr12(+):8010803480113000

Pgr15l

protein_coding

Plagl1

protein_coding

Sesn1

protein_coding

Jun

protein_coding

Zfp36l1

protein_coding

chr15(-):5206661-5244187
chrX(+):135834109135844731
chrX(+):101794592101798644
chr4(-):143894237143900380
chr2(-):113500679113504034

Ptger4

protein_coding

Gprasp2

protein_coding

8030474K03Rik

protein_coding

Pramef6

protein_coding

Gm13964

processed_transcript

chr17(-):6738041-6782784
chr5(+):5771802158132240
chr4(-):126150602126163491
chr4(+):8878496388786518
chr5(-):116408491116422864
chr4(+):8879080588792360
chr2(+):163122606163144267

Ezr

protein_coding

Pcdh7

protein_coding

1700029G01Rik

protein_coding

Gm13276

pseudogene

Hspb8

protein_coding

Gm13276

pseudogene

Gm11454

processed_transcript
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Table 3.2. Genes not zygotically activated, but whose expression is up-regulated
following inhibition of the maturation-associated increase in SIN3A.
Annotation
ID
17270727
17297591
17318403
17231033
17240606
17400000
17335788
17312278
17250517
17287245
17249962
17356427
17270999
17374792
17458514
17431478
17253832
17275015
17327038
17506697
17282776
17500535
17391233

SPOT ID
chr11(-):106126336106127351
chr14(+):2126362421263859
chr15(-):7621410176214205
chr1(-):191170296191183340
chr10(-):4358378343584264
chr3(+):9355508093564645
chr17(+):3105960431059731
chr15(+):7575985975759989
chr11(+):6080457860804703
chr13(+):4971411949714240
chr11(+):5812606858128512
chr19(+):54476985455945
chr11(-):106783171106783271
chr2(+):119325784119335962
chr6(+):4982271049829507
chr4(-):135541888135573630
chr11(+):7970463079705420
chr12(+):3599290736004087
chr16(+):9137278391405589
chr8(+):123653929123663884
chr12(-):8688070386884814
chr8(+):3480729734819894
chr2(-):127138769127143457

Gene name

Biotype

Gm11672

processed transcript

7SK

misc_RNA

U6

snRNA

Atf3

protein_coding

Cd24a

protein_coding

S100a10

protein_coding

5S_rRNA

rRNA

SNORA17

snoRNA

SNORA25

snoRNA

SNORA24

snoRNA

Gm12246

processed transcript

Fosl1

protein_coding

Ddx5

protein_coding

Dll4

protein_coding

Npy

protein_coding

Grhl3

protein_coding

Gm11205

processed transcript

Agr2

protein_coding

NA

NA

Rhou

protein_coding

6430527G18Rik

protein_coding

Dusp4

protein_coding

Itpripl1

protein_coding
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17276139
17366812
17366848
17333121
17336494
17439511
17335818
17225191
17439184
17274184
17366788
17366824
17402181
17464549
17250322
17292507
17274959
17223848
17415310
17540374
17216402
17233357
17286703
17225224
17366644
17364521

chr12(+):7130988471320107
chr2(+):1048941010489533
chr2(+):1049679110496914
chr17(+):84344238442496
chr17(+):3426320934269418
chr5(+):9818086998187448
chr17(+):3129548331350709
chr1(-):8666629186670573
chr5(+):9326725793276231
chr12(+):1449456114495157
chr2(+):1048449010484613
chr2(+):1049186010491983
chr3(+):121723537121735052
chr6(-):36856773764713
chr11(+):5992149959921889
chr13(-):4997625849976488
chr12(+):3395767133959831
chr1(-):6510038965103373
chr4(+):8877617688777731
chrX(-):1589666315896769
chr1(+):106861173106883348
chr10(+):5748638557513143
chr13(+):4072780840735145
chr1(-):8714765587156521
chr2(+):98772569878869
chr19(-):4055025740588463

Dact1

protein_coding

AL772216.12

miRNA

AL772216.12

miRNA

T

protein_coding

H2-Ab1

protein_coding

Prdm8

protein_coding

Slc37a1

protein_coding

Nppc

protein_coding

Ccng2

protein_coding

Gm9847

protein_coding

AL772216.36

miRNA

AL772216.36

miRNA

F3

protein_coding

Calcr

protein_coding

1810063I02Rik

processed transcript

Gm17611

protein_coding

Twist1

protein_coding

Cryga

protein_coding

Gm13276

pseudogene

U6

snRNA

Serpinb5

protein_coding

Hsf2

protein_coding

Gm16989

lincRNA

Ecel1

protein_coding

Gm13256

processed transcript

Aldh18a1

protein_coding
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17272857
17415305
17281885
17422443
17282216
17253133
17395499
17286295
17366790
17233920
17296896
17268137
17454995
17464718
17500097
17288836
17487422
17407903
17379887
17279011
17525578
17281337
17519967
17373943
17366687
17504293

chr11(-):119077571119086237
chr4(+):8877324888774803
chr12(-):7310025973113414
chr4(+):154960923154962371
chr12(-):8010776080113013
chr11(+):7617967176214827
chr2(-):180099465180104488
chr13(+):3074922630766927
chr2(+):1048505110485176
chr10(+):6338244363408840
chr14(+):48604065021482
chr11(-):9504447495076801
chr5(-):144735915144761649
chr6(-):76751697693254
chr8(+):2501721125023260
chr13(+):7767682177676951
chr7(-):1975613119771016
chr3(-):9579669995796884
chr2(+):167248317167248578
chr12(+):110841029110843804
chr9(-):3722914937255738
chr12(-):5754063157546121
chr9(+):8584238085847055
chr2(+):105668896105703160
chr2(+):1037045110595253
chr8(+):9535226895374293

Cbx4

protein_coding

Gm13276

pseudogene

Six4

protein_coding

Hes5

protein_coding

Zfp36l1

protein_coding

Fam57a

protein_coding

Gm17180

processed transcript

Irf4

protein_coding

AL772216.29

miRNA

Dnajc12

protein_coding

Gm3242

pseudogene

Itga3

protein_coding

Tmem130

protein_coding

Asns

protein_coding

Tm2d2

protein_coding

SNORA17

snoRNA

Bcam

protein_coding

U1

snRNA

Gm17544

protein_coding

4921507G05Rik

lincRNA

Slc37a2

protein_coding

Foxa1

protein_coding

Tpbg

protein_coding

Pax6

protein_coding

Sfmbt2

protein_coding

Mmp15

protein_coding
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17288057
17293515
17356383
17308881
17541383
17336921
17515436
17409154
17232853
17217440
17375503
17520315
17445236
17450366
17489905
17351485
17344124
17277622
17374738
17302598
17483565
17231855
17257937

chr13(+):6213676262136831
chr13(-):6254343462543503
chr19(+):52983315308739
chr14(-):7928874979301635
chrX(-):4817196948208878
chr17(+):3506538835070050
chr9(+):2241157722444681
chr3(-):108012250108017973
chr10(+):4147631441487032
chr1(+):134405781134411740
chr2(+):122636986122641191
chr9(+):9225005792272561
chr5(+):150708044150708149
chr5(-):103989762104021919
chr7(-):3822065438227994
chr18(+):6764159967654162
chr17(-):3495224034952309
chr12(+):8733248887335655
chr2(+):119167773119172390
chr14(+):110970788110971471
chr7(+):127983079127985701
chr10(+):1935653919358606
chr11(+):111066164111076825

SNORA32

snoRNA

SNORA32

snoRNA

Gal3st3

protein_coding

1190002H23Rik

protein_coding

Zdhhc9

protein_coding

Ly6g6c

protein_coding

9530077C05Rik

protein_coding

Gstm1

protein_coding

Mical1

protein_coding

Cyb5r1

protein_coding

AA467197

protein_coding

Plscr1

protein_coding

U6

snRNA

Hsd17b11

protein_coding

Plekhf1

protein_coding

Psmg2

protein_coding

1110038B12Rik

processed transcript

Gm17256

lincRNA

Gchfr

protein_coding

Gm6280

protein_coding

B230325K18Rik

protein_coding

Olig3

protein_coding

Kcnj2

protein_coding
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Table 3.3. qRT- PCR confirmation of four transcripts from each class whose
expression was increased following inhibition of the maturation-associated
increase in SIN3A.

Probe

Sample

CT1

CT2

Mean CT

DCT

DDCT

Fold
change

Atf3

control

34.13

34.06

34.10

10.09

0.00

1.00

Sin3a KD

32.00

32.16

32.08

8.04

-2.05

4.13

control

36.00

36.27

36.14

12.13

0.00

1.00

Sin3a KD

37.39

36.88

37.14

13.10

0.97

0.51

control

35.00

34.93

34.97

10.96

0.00

1.00

Sin3a KD

34.93

34.54

34.74

10.70

-0.26

1.20

control

33.00

32.52

31.24

7.23

0.00

1.00

Sin3a KD

30.82

30.79

30.81

6.77

-0.47

1.38

control

36.85

37.42

37.14

13.13

0.00

1.00

Sin3a KD

36.00

36.05

36.03

11.99

-1.14

2.20

control

33.57

33.62

33.60

9.59

0.00

1.00

Sin3a KD

32.23

32.00

32.12

8.08

-1.51

2.85

control

35.00

35.22

35.11

11.10

0.00

1.00

Sin3a KD

32.90

33.27

33.09

9.05

-2.06

4.16

control

33.23

33.00

33.12

9.11

0.00

1.00

Sin3a KD

31.93

31.64

31.79

7.75

-1.36

2.57

control

24.02

24.00

24.01

Sin3a KD

24.10

23.98

24.04

Calcr

Cd24a

Crabp1

Hsd17b11

Krt18

Osr2

Rgs16

H2a
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3.2 Discussion
During early mouse development, a highly differentiated female germ cell,
the oocyte, transforms into a zygote, which is the source of the undifferentiated
totipotent blastomeres. Surprisingly, this biological switch occurs during a
transcriptionally inactive period; therefore, this transformation must rely on the
transcripts bestowed to the zygote by the mother (the oocyte) until the zygotic
genome is activated. During this transition from maternal to zygotic control of
cellular functions, the major ZGA promotes a dramatic change of global gene
expression (Hamatani et al., 2004) that is essential for continued development
beyond the 2-cell stage. Superimposed on ZGA and reprogramming is the
formation of a chromatin-mediated transcriptionally repressive state that
promotes the repression of endogenous genes during the 2-cell stage
(Wiekowski et al., 1991; Majumder et al., 1993; Davis et al., 1996). This
transcriptionally repressive state is relieved when global histone hyperacetylation
is induced (Wiekowski et al., 1991; Davis et al., 1996). Although the genes that
are reprogrammed have been identified, a major unresolved problem is how this
reprogramming of global gene expression occurs through the utilization of a
maternally-derived transcription machinery.
Several modes of regulation may be responsible for ZGA and the
subsequent reprogramming of global gene expression with a maternally-derived
transcription machinery in early mouse development. One locus of regulation
may be at the level of RNA polymerase II, particularly the post-translational
changes affecting this enzyme. Phosphorylation of RPB1, most likely by MAP
kinase, occurs in mouse oocytes; the phosphorylation may destabilize the
holoenzyme and be responsible for the global transcriptional silencing observed
in these cells, which is continued into the 1-cell stage of mouse preimplantation
development (Wei et al., 2015; Abe et al., 2010). Because the amount of the
hyperphosphorylated form of RPB1 decreases rapidly following fertilization when
the enzyme responsible for the enzyme’s phosphorylation is inactive in Xenopus
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(Bellier et al., 1997), CTD phosphatases may counteract the action of MAP
kinase, leading to dephosphorylation of the hyperphosphorylated form of RPB1 in
mouse 1-cell embryos and activation of zygotic transcription.
Changing the composition of the chromatin such as the elimination of
maternal histone variants associated with transcriptional repression may be
responsible for the global transcriptional activation and subsequent
reprogramming of gene expression in mouse embryos. Several histone variants
associated with transcriptional repression are lost following fertilization. For
example, the maternal histone variant macroH2A, which is a core histone related
to canonical histone H2A (Pehrson and Fried, 1992), is generally involved with
transcriptionally repression due to its association with condensed chromatin such
as inactive genes and the inactive X chromosome (Buschbeck et al., 2009;
Costanzi and Pehrson, 1998). During ES cell differetiation and in development,
macroH2A is deposited at pluripotency genes and can act as an epigenetic
barrier during the process of somatic cell reprogramming (Gaspar-Maia et al.,
2013). Interestingly, in developing and maturing mouse oocytes, macroH2A is
associated with chromosomes and is lost from the embryo following fertilization,
specifically by the late 2 pronuclei stage (Chang et al., 2005). MarcroH2A does
not reappear until after the 8-cell stage, and its expression persists in the morula
and blastocysts, which is the stage at which the first cellular differentiation event
occurs during development.
Another elegant, but simple solution to promote the success of
reprogramming gene expression is the translational recruitment of dormant
maternal mRNAs that encode for chromatin-modifying-related factors during
oocyte maturation and following fertilization in the mouse. These critical factors
will rearrange the chromatin structure of the early embryo, and subsequently alter
RNA polymerase II promoter accessibility to elicit transcription and the
subsequent reprogramming of global gene expression. By utilizing the
recruitment of dormant maternal mRNAs for translation during oocyte maturation,
the oocyte is able to utilize a mechanism to synthesize a new functional protein
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product at the appropriate developmental time without new transcription.
The mechanism for the translational recruitment of dormant maternal
mRNAs is well understood in oocytes (Groppo and Richter, 2009). In general,
many dormant but stable mRNAs that have a relatively short poly (A) tail in the
oocyte are inhibited from translation by sequence-specific RNA binding proteins
such as Maskin, which affects translational initiation. In particular, Maskin, which
interacts with CPE-containing mRNAs that are bound by CPEB, weakly interacts
with eukaryotic translation initiation factor 4E (eIF4E) and prevents its interaction
with eIF4G and leads to translational repression (Stebbins-Boaz et al.,
1999). When the oocyte resumes meiosis, the bound CPEB stimulates the
elongation of the poly (A) tail, which then binds poly(A) binding protein
(PABP). PABP then associates with eIF4G and helps disrupt the Maskin-eIF4E
interaction to allow for the translational activation of the CPE-containing mRNAs
(Richter and Sonenberg, 2005). The dissociation of Maskin from eIF4E and
translational activation is also mediated by several CDK1 driven phosphorylation
events of Maskin (Barnard et al., 2005).
Previously, the identification of the dormant maternal mRNAs that undergo
translational recruitment following oocyte maturation was serendipitous. For
example, c-mos, a MAPK pathway activator, was serendipitously identified as a
dormant maternal transcript that is recruited for translation during oocyte
maturation. The translational recruitment of this transcript is needed to maintain
cellular arrest at metaphase II (Colledge et al., 1994; Sheets et al. 1995; Sagata,
1997). However, these dormant maternal mRNAs are now being identified on a
global scale by using previously generated data from microarray experiments in
which oligo(dT) primers were used to generate cDNA from mouse oocytes and
embryos (Zeng et al., 2004). The elongation of the poly (A) tail that is associated
with translational activation provides for a more efficient oligo(dT) priming of RNA
isolated from the mouse oocytes and embryos. The increased priming efficiency
associated with oligo(dT) primers results in an increase in the relative abundance
of the transcript in 1-cell embryos when compared to full-grown GV-intact
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oocytes.
After analyzing the microarray data, many transcripts displayed an
increase in relative abundance between the full-grown GV-intact oocyte and 1cell stage, and some of these potential dormant maternal transcripts that are
recruited for translation during oocyte maturation and/or following fertilization
encode for chromatin-modifying-related factors (Zeng et al., 2004). A few such
transcripts were Sin3a, a chromatin remodeler (Bansal et al., 2016), Rbbp7, a
core histone biding protein (Verreault et al., 1998), and Ezh2, a histone H3K27
methyltransferase (Cao and Zhang, 2004). A prominent characteristic of these
potentially translationally recruited transcripts is their raw score for their relative
abundance is high when compared to the value of the normalized chip. This high
abundance of the translationally recruited maternal transcript provides a strategy
for the oocyte to synthesize a large amount of protein during a short period of
time before the function of the protein is needed. The following work focuses on
Sin3a because SIN3A is essential for mouse development (Cowley et al., 2005;
Dannenberg et al., 2005) and present in a HDAC-containing complex (Bansal et
al., 2016), which have a role in the formation of the transcriptionally repressive
state that develops during ZGA and the reprogramming of gene expression (Ma
and Schultz, 2008).
During oocyte maturation and following fertilization, elements in the 3’
UTR, such as the cytoplasmic polyadenylation element (CPE, U4-5A1-2U),
polyuridine stretch and polyadenylation signal sequence (AAUAAA), control the
translation of certain maternal mRNAs by elongating the poly (A) tail (Fox et al.,
1990; Oh et al., 2000). After searching the 3’ UTR of Sin3a transcript for these
elements, a potential CPE (U5AU) and a polyuridine stretch (U13) are present
within ~210 nucleotides and directly preceding the polyadenylation signal
sequence. These elements may contribute to the increase in the amount of
SIN3A protein observed during oocyte maturation and following fertilization by
directing the polyadenylation of the Sin3a transcript that will lead to the
translational activation of the transcript. Examination of microarray data of oligo
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(dT) primed mouse oocyte and 1-cell embryo cDNA reveal an elevation in the
relative abundance of Sin3a transcript between the full-grown GV-intact oocytes
and 1-cell stages (Zeng et al., 2004). The elevation in the relative abundance of
the Sin3a transcript likely reflects the polyadenylation of the transcript during
oocyte maturation that leads to an increased priming efficiency of the oligo (dT)
primer during reverse transcription since essentially no new transcription occurs
between the two stages. These results are consistent with Sin3a mRNA being a
dormant maternal mRNA that is recruited for translation during oocyte maturation
and following fertilization. It would be interesting to mutate the CPE located
within the 3’ UTR of Sin3a mRNA to determine if it attenuates the maturationassociated increase in SIN3A, and the polyuridine stretch (U13) to determine if
the increase in maternal SIN3A following fertilization is impaired.
A more recent genome-wide profiling of polysome mRNA identified an
enrichment of a motif for the RNA-binding protein deleted in azoospermia-like
(DAZL) along with the CPE motif within the 3’ UTR of mRNAs recruited to the
polysomes during mouse oocyte maturation (Chen et al., 2011). Although DAZL
has been proposed to function as a translational activator, there is evidence
supporting it as a translation repressor in full-grown GV-intact oocytes.
Interestingly, the 3’ UTR of Sin3a mRNA contains several putative DAZL
elements within 200 nucleotides of the polyadenylation signal sequence. It would
be interesting to determine if these motifs have a role in the translational
recruitment of the Sin3a transcript to the polysomes during oocyte maturation
and/or the translational repression of the Sin3a transcript in mouse oocytes.
The restricted presence of the maturation-associated increase in SIN3A
protein mainly to the 1-cell stage likely constrains its function to this short window
of mouse preimplantation development. Because there was a relatively
significant amount of Sin3a transcript present at the 2-cell stage and maternal
SIN3A degradation was substantially inhibited by a proteasome inhibitor, the
dramatic reduction of maternal SIN3A to nearly undetectable levels by the 2-cell
stage suggest that the protein loss is likely a result of proteasome-mediated
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degradation rather than the decrease in the relative abundance of Sin3a mRNA
between the MII and 2-cell stages. The low SIN3A protein levels can also result
from a decrease in protein synthesis of SIN3A. If the loss in the increase in
maternal SIN3A protein is mainly due to degradation, it leads to an emerging
question as to which pathway is involved in the degradation of maternal SIN3A
protein: ubiquitin-dependent or ubiquitin-independent proteasomal degradation.
If maternal SIN3A undergoes clearance via the ubiquitin-independent
proteasomal degradation pathway, it would be interesting to determine what
mechanism is in place to protect maternal SIN3A from degradation to allow
proper protein accumulation between the MII and 1-cell stages. It may be that
assembly of SIN3A into the SIN3A-co-repressor complex protects SIN3A from
20S proteasomal degradation, as seen when CDK inhibitor p21 (WAF1/CIP1)
binds directly to cyclin D1 (Touitou et al., 2001; Coleman et al., 2003). It is
possible that a post-translational modification occurs following ZGA that
dissociates SIN3A from the complex, and allows for it to be degraded by the
proteasome.
Because the function of maternal SIN3A may be limited to a short window
of mouse preimplantation development and the epigenetic modifications of the
paternal and maternal genomes are distinct at fertilization and during the 1-cell
stage (Santos et al., 2005; Erhardt et al., 2003; Lepikhov and Walter, 2004; Liu et
al., 2004), I focused my analysis mostly on determining the effects of depleting
maternal SIN3A in 1-cell embryos that were derived from MII eggs fertilized in
vitro. Although maternal SIN3A appears equally distributed to both pronuclei in
the 1-cell mouse embryo, differences in chromatin-association of nuclear proteins
at this stage is know to exist. For example, PGC7/STELLA appears in both
pronuclei at the 1-cell stage, but has a weak association to the paternal genome
(Nakamura et al., 2012). However, no difference in the chromatin-association of
maternal SIN3A was observed between the maternal and paternal pronuclei
when 1-cell embryos were permeabilized prior to fixation. Any difference in
localized gene occupancy between the maternal and paternal remains unknown
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and can only be addressed once chromatin immunoprecipitation assays allow for
small cell numbers to be analyzed.
The HDAC inhibitor TSA led to histone hyperacetylation, whereas blocking
the maturation-associated increase in maternal SIN3A surprisingly results in no
histone hyperacetylation. Rather, histone hypoacetylation is seen in the 1-cell
embryos depleted of maternal SIN3A. Although a decrease in nuclear HDAC2
was seen in Sin3a null oocytes, the amount of nuclear HDAC1 remained
unchanged (Ma et al., 2015). Because removal of HDAC1, but not HDAC2 in
preimplantation embryos leads to global histone hyperacetylation (Ma et al.,
2008), a likely decrease in nuclear HDAC2 when the maturation-associated
increase in maternal SIN3A is inhibited will not likely effect the global histone
acetylation state of 1-cell mouse embryos. However, as seen with oocytes, the
amount of nuclear HDAC1 likely remains unchanged in 1-cell embryos depleted
of maternal SIN3A, and therefore would still be present and able to function in 1cell embryos. Because the SIN3A-co-repressor complex is a major HDAC1 and
HDAC2 containing complex and SIN3A is an essential component of the multisubunit complex, depleting maternal SIN3A may likely allow HDAC1 and the
decreased nuclear amount of HDAC2 to associate with other HDAC1/2containing complexes. If the other HDAC1/2-containing complexes have greater
enzymatic activity than the SIN3A-co-repressor complex, then the observed
histone hypoacetylation could likely occur.
The observed histone hypoacetylation and depletion of maternal SIN3A in
mouse 1-cell embryos had no effect on global transcription in the zygote,
however, the histone hypoacetylation could account for the 50% reduction in
global transcription observed in the 2-cell embryos depleted of maternal SIN3A
because of the known links between transcription and the histone modifications
that are affected in these embryos. For example, the enrichment of H4K12ac in
transcribed regions, which was globally decreased in the maternal SIN3Adepleted embryos, is associated with transcriptional elongation (Cho et al., 1998)
and could contribute to the reduced global transcription at the 2-cell stage.
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Furthermore, the hypoacetylation of H4K8ac, which is enriched in the promoter
and body of transcribed genes and linked to transcriptional activation (Wang et
al., 2008), and H3K18ac, which is enriched around the transcription start site and
may be important for recruiting Pol II to target genes to initiate transcription (Jin
et al., 2011), could also contribute to the decreased global transcription.
Blocking the maturation-associated increase in maternal SIN3A led to a
developmental arrest at the 2-cell stage. The function of only a few other genes
(Mater, mHR6A, Trim24, and Brg1) has been identified as being required for
embryonic development beyond the 2-cell stage as Sin3a (Tong et al., 2000;
Roest et al., 2004; Torres-Padilla and Zernicka-Goetz, 2006; Bultman et al.,
2006). Failure to activate the zygotic genome or successfully reprogram the
pattern of gene expression that accompanies ZGA is a source for the
developmental arrest. The expression of a restricted subset of genes that are
normally and not normally activated during ZGA and reprogramming of gene
expression in maternally depleted SIN3A 2-cell embryos likely underlines the
observed 2-cell arrest. The observation that only a restricted subset of genes
that are normally activated during ZGA are misexpressed is consistent with
SIN3A co-repressor complex being one of several HDAC1/2-containing
complexes that may have a role in the repression of genes during the formation
of the global transcriptionally repressive state that develops during ZGA.
Analysis of the misexpressed genes in maternal SIN3A-depleted embryos
was uninformative in providing a framework for understanding the mechanistic
relationship between the depletion of maternally derived SIN3A co-repressor
complex and relief of repression of a restricted subset of genes. Mapping of the
misexpressed genes to chromosomes did not reveal unexpected gene clusters,
and the misexpressed genes represented multiple classes of genes and did not
solely represent one gene class (e.g., noncoding RNAs). However, the analysis
of the misexpressed genes revealed that a bivalent promoter, which carry both
H3K4me3 an H3K27me3 in mouse embryonic stem cells, marked about 40
genes whose expression was increased in SIN3A maternally depleted 2-cell
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embryos. It would be interesting to determine whether the bivalent chromatin
mark is present at the promoters of these genes in 2-cell mouse embryos and
observe how they change over the course of preimplantation development.
Investigating whether one or both of these histone modifications are needed for
the recruitment of the SIN3A-co-repression complex to these genes should
facilitate the development of a working model outlining the linkage between the
maternal SIN3A-co-repression complex and the reprogramming of gene
expression. However, these questions could only be addressed once chromatin
immunoprecipitation assays allow for small cell numbers because of the
excessive amount of time and effort needed to generate the biological samples
that were used in this study.
The experiment where elevated levels of maternal SIN3A was maintained
beyond the time when it normally decreases to undetectable levels yields insights
beyond what I was expecting to discover. Analysis of the control embryos
suggest that development to the blastocyst stage depends on the control cRNA
that is injected and highlights the need to be cautious about choosing a proper
control in the experiment. We observed that mCherry cRNA is detrimental to
blastocyst developmental while Luc cRNA and buffer had no effect. The
overexpression experiment was unsuccessful because of the rapid loss of the
exogenously expressed SIN3A, a finding consistent with the endogenous
maternal SIN3A. In order to assess whether the rapid loss of maternal SIN3A is
essential for mouse preimplantation development, identifying and then mutating
the amino acid sequences responsible for the rapid turnover of (e.g., of
destruction box) (Glotzer et al., 1991) SIN3A may allow for such a study to be
conducted.
In summary, the presented data provide a role for SIN3A co-repressor
complex, an HDAC-containing complex, in the development of the
transcriptionally repressive state during mouse preimplantation development. In
this model, SIN3A is encoded by a dormant maternal mRNA that is recruited for
translation during oocyte maturation and following fertilization. Blocking the
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recruitment of maternal Sin3a mRNA impairs the expression of a subset of
zygotically and non-zygotically activated genes during the establishment of the
transcriptionally repressive state that is superimposed on ZGA. These results
provide a unique approach with which to study the reprogramming of gene
expression during preimplantation development and leads to a number of
additional questions requiring further research. It would certainly be interesting
to determine the precise mechanism between the loss of maternal SIN3A and
relief of repression of the genes misexpressed in maternal SIN3A-depleted
embryos. Overall, the data implicate the role for the translational recruitment of
dormant maternal mRNAs encoding chromatin remodelers like SIN3A as a posttranscriptional mechanism for how reprogramming of gene expression occurs
utilizing a maternally-derived transcription machinery. Interestingly, what
emerges from the analysis of the microarray data of oligo (dT) primed mouse
oocyte and 1-cell embryo cDNAs is that the transcripts that show a relative
increase in abundance between the full-grown GV-intact oocyte and 1-cell stage
encode for proteins which are central to cellular processes that should either not
function or function minimally in the oocyte but then are required by the 1-cell
stage of development. For example, mRNAs are relatively stable during oocyte
growth due to the RNA binding protein MSY2 (Yu et al., 2004). The mRNA
degradation machinery during this period is minimally functional and the
resumption of meiosis triggers a transition from maternal mRNA stability to
instability, in which MSY2 becomes phosphorylated by CDC2A. This
phosphorylation event makes maternal mRNAs more susceptible to the oocyte’s
RNA degradation machinery (Medvedev et al., 2008). DCP1A and DCP2,
proteins responsible for decapping mRNA, are encoded by dormant maternal
mRNAs that are recruited for translation during oocyte maturation. The increase
in both these proteins ensures that the maternal mRNAs are stable in the oocyte
but are unstable and degraded following oocyte maturation (Ma et al., 2013).
Oocytes should not have the capacity to undergo a round of DNA replication, but
need to replicate their DNA following fertilization. ORC6L and CDC6, critical
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factors for assembly of a functional origin of replication complex, are encoded by
dormant maternal mRNAs that are recruited for translation during oocyte
maturation (Murai et al., 2010; Anger et al., 2005). The recruitment of these
transcripts during oocyte maturation ensures that DNA replication does not occur
in the oocyte but that the 1-cell embryos are capable of undergoing a round of
DNA replication. The active DNA demethylation event occurring solely on the
paternal genome during the 1-cell stage of mouse development is mediated by
TET3 (Iqbal et al., 2011; Gu et al., 2011; Wossidlo et al., 2011). Oocyte
maturation and fertilization is accompanied by an increase in the protein
synthesis of TET3 that results in loss of the paternal 5mC, and appearance of
hydroxymethylcytosine (5hmC) (Inoue and Zhang, 2011). Inhibiting the increase
in maternal TET3 using a siRNA approach results in the inhibition of the oxidation
of 5mC to 5hmC, and surprisingly, the loss of maternal TET3 had no effect on
ZGA or transponsable element activation (Inoue et al., 2012). The increase in
TET3 ensures the 1-cell embryo, but not the oocyte, undergoes active DNA
demethylation following fertilization.
A similar conclusion emerged when a different approach was undertaken
to determine, at a global scale, which maternal mRNAs are recruited for
translation during oocyte maturation. Results from genome-wide analysis of
transcripts that were recruited to polysomes during mouse oocyte maturation
revealed that these transcripts encode for well-established regulators of the cell
cycle, like components of the spindle assembly checkpoint (Mad2 and Bub1b)
and the anaphase-promoting complex (Apc1, Apc10) (Chen et al., 2011).
Interestingly, the processes that are encoded for by the transcripts recruited to
the polysomes are not limited to regulators of cell cycle, but include chromatin
remodelers and transcription regulators, which is consistent with my findings from
the microarray data. The coordinated translational recruitment of specific
maternal mRNAs during oocyte maturation and following fertilization is a
mechanism the oocyte utilizes and is likely essential for the critical events that
take place during the initial stages of embryo development until transcription is
77

activated and the embryo assumes control of development.
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